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TABLE OF STANDARD AMINO ACID ABBREVIATIONS 
 
 
1-letter 
code 
3-letter 
code 
Name 1-letter 
code 
3-letter 
code 
Name 
A Ala alanine M Met methionine 
C Cys cysteine N Asn asparagine 
D Asp aspartic acid P Pro proline 
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ABSTRACT  
 
The heterogeneity of the metal content observed in Metallo-ß-Lactamases (MBLs) 
hampers the design of potential inhibitors. In the first part of the work, three 
representative members of the MBLs, namely BcII, CphA and L1 were investigated 
using mass spectrometric and spectroscopic methods. Experimental parameters for 
the detection of the metal-protein and ternary metalloprotein-inhibitor complexes 
using ESI-MS1 were evaluated and optimized. SAR1 determined in the gas phase 
were in agreement with kinetic assays performed in solution. This demonstrates the 
suitability of this technique for the screening for new inhibitors of MBLs and for the 
detection of metal:enzyme:inhibitor ratios. Competition-titrations in combination with 
ESI-MS, revealed that for different subclasses of the MBL, the inhibition by (R,S)-
thiomandelate and D-captopril is strongly influenced by the nature of the metal ion 
and the metal content of the protein.  
In the second part of the work, the metal ion dependent flexibility of different parts of 
the BcII protein was investigated using HDX-MS1. It was shown that the metal-free 
enzyme was the least ordered structure and that the high flexibility at the metal 
binding site and the domain interface region in the Cd1-enzyme might facilitate the 
transfer of the metal between the two binding sites. These findings deliver important 
parameters for future development of efficient inhibitors for these enzymes. 
 
 
 
1Abbreviations used are: ESI-MS, electrospray ionization mass spectrometry; SAR, 
structure activity relationship; HDX-MS, hydrogen deuterium exchange mass 
spectrometry  
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ZUSAMMENFASSUNG 
 
Die heterogene Metallbesetzung in Metallo-ß-Lactamasen (MBLs) ist einer der 
Hauptgründe für den bislang geringen Erfolg bei der Entwicklung effizienter 
Inhibitoren für diese Enzymklasse. Im ersten Teil der Arbeit wurden drei 
repräsentative Vertreter der MBLs (BcII, CphA und L1) mit massenspektrometrischen 
und spektroskopischen Methoden untersucht. Es wurden Methoden der „nicht 
denaturierenden“ ESI-MS1 für den Nachweis von Metall-Protein- sowie ternärer 
Metallprotein-Inhibitor-Interaktionen entwickelt. Die mittels ESI-MS in der Gasphase 
ermittelten SAR1 stimmten sehr gut mit den zuvor in Lösung ermittelten überein. 
Somit konnte gezeigt werden, dass ESI-MS eine geeignete Methode für die 
Bestimmung von Metall-Enzym-Inhibitor-Stöchiometrien und damit für die 
Identifizierung neuer effizienter Inhibitoren darstellt. Durch die Kombination von ESI-
MS Experimenten mit Konkurrenztitrationen zeigte sich, dass die Hemmung 
verschiedener MBL-Subklassen mittels (R,S)-Thiomandelsäure und D-Captopril stark 
von der Art des gebundenen Metalls sowie von der Metall-Protein-Stöchiometrie 
beeinflusst wird.  
Im zweiten Teil der Arbeit konnte mittels HDX-MS1 gezeigt werden, dass beim 
metallfreien Enzym die Sekundärstruktur am wenigsten ausgeprägt ist und dass das 
Cd1-BcII Enzym der metal-freien BcII Spezies sehr zu ähneln scheint, wenn nur das 
aktive Zentrum und die Interdomainen-Region betrachtet werden. Dies liefert ein 
tiefergehendes Verständnis der MBL sowie Grundlagen zur Entwicklung neuer 
Inhibitoren. 
 
 
1Abkürzungen: ESI-MS, Massenspektrometrie der Electrospray Ionisierung; SAR, 
Struktur Aktivitäts Beziehungen; HDX-MS, Wasserstoff Deuterium Austausch 
Massenspektrometrie  
  INTRODUCTION 
  
 
13
INTRODUCTION 
 
One of the major bacterial resistance mechanisms against ß-lactams is the 
production of metallo-ß-lactamases (MBLs); they can inactivate ß-lactams by 
hydrolysing their ß-lactam ring using zinc ions as cofactors. The emergence of MBLs 
in pathogenic bacterial strains and their low sensitivity against carbapenems, 
compounds usually administrated for the inhibition of the serine-ß-lactamases, make 
them clinically relevant. To date, not a single MBL inhibitor has been found to be 
used in clinical therapy settings. In fact, the design of potent drugs is hindered by the 
little understanding of the real metal state of MBLs in vivo (1). The importance of the 
metal requirement for catalytic activity of the three subclasses B1-B3 MBLs is still 
matter of debate.  
Although most crystal structures of subclass B1 enzymes show that both metal sites 
are occupied (1), the enzymes BcII from Bacillus cereus 569/H/9, CcrA from 
Bacteroides fragilis, BlaB from Chryseobacterium meningosepticum, and IMP-1 from 
Pseudomonas aeruginosa are active as mono- as well as di-zinc enzymes (2-5). 
Moreover, the B2 enzymes CphA from Aeromonas hydrophilia and ImiS from 
Aeromonas veronii bv. sobria are most active in their monozinc form (6, 7). For 
enzymes belonging to the subclass B3, which are generally considered as dizinc 
enzymes, it has been shown that for instance L1 from Stenotrophomonas maltophilia 
is also active as a monozinc enzyme (4). More recently, GOB from Elizabethkingia 
meningoseptica has been reported as a mono-zinc subclass B3 enzyme with a novel 
active site geometry (8). 
In presence of substrates or inhibitors, the MBLs can adopt different metal 
stoichiometries. Wommer et al., 2002 showed that the substrate imipenem induced 
negative cooperativity in metal ion binding for representative enzymes of subclasses 
B1-B3 (4). The authors proposed that the monozinc-MBLs are physiologically 
relevant species due to the fact that the free zinc concentration in the bacterial 
cytosol is only femtomolar. Binuclear zinc MBLs might be an artefact due to the high 
concentrations of zinc usually required for its production in vitro. 
Known inhibitors of MBLs have also been shown to influence the MBL metal content. 
Most of the reported data were acquired on cadmium-substituted MBLs, also 
representating catalytically active species. For the cadmium-substituted BcII enzyme 
  INTRODUCTION 
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positive cooperativity in metal binding was observed in presence of thiomandelate, a 
known MBL broad-spectrum thiol inhibitor (9), whereas the presence of D-captopril 
(another potent in-vitro MBL thiol inhibitor) decreased the affinity for a second 
cadmium ion binding (10). Furthermore, structural data in solution and in the crystal 
state have revealed that D-captopril adopts different binding modes when bound to a 
sub-class B1, B2 or B3 MBL (1). 
Another particular feature of the MBLs is the important variation in position, number 
and type of solvent molecules required for metal coordination. The positions of the 
amino acids interacting with the metal ions can be different even within the same 
subclass. Perturbed angular correlation spectroscopy (PAC) or Nuclear magnetic 
resonance spectroscopy (NMR) have been used to provide some valuable 
information on the metal coordination geometry. The combination of PAC and NMR 
have revealed a dynamic process at the metal binding sites, demonstrating an 
intramolecular exchange of the cadmium between the two available binding sites 
(11).  
 
AIMS OF THE WORK 
In the first part of this work and in collaboration with partners from the European 
network MEBEL, it has been set to develop and apply a “non-denaturing”- 
Electrospray Ionization Mass Spectrometry (ESI-MS) method in order to detect 
potential metalloprotein-ligand complexes with the aim to identify new MBL inhibitors. 
Additionnally, the influence of the inhibitors on the metal stoichiometry in MBLs has 
been investigated using the ESI-MS approach together with competition titrations 
performed in solution.  
The second part of the work is focused on the overall protein flexibility and the 
modification of MBL active site dynamics upon metal and ligand binding using a 
hydrogen-deuterium exchange mass spectrometry (HDX-MS) method. 
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1 THEORETICAL BACKGROUND 
1.1 ß-Lactam resistance 
ß-lactam antibiotics are potent antimicrobial agents that inactivate the 
transpeptidases (eg. Penicillins-Binding Proteins or PBPs) involved in the bacterial 
cell wall synthesis (12). They have been administrated for over five decades for the 
treatment of community-acquired infections. However, the emergence of several 
pathogenic strains resistant to ß-lactams led to the revision of the current therapies. 
In fact, bacteria have developed different escape strategies against the antimicrobial 
drugs. The most common mechanism of resistance is the production of ß-lactamases 
which can inactivate the antibiotic by hydrolysing the amide bond of its ß-lactam ring 
(Figure 1.1). 
 
 
 
 
 
 
 
 
 
Figure 1.1: Scheme of the hydrolysis of a ß-lactam antibiotic (benzylpenicillin) by a ß-
lactamase.  
 
1.2 ß-Lactamases 
ß-lactamases have been divided into four classes (A-D) based on either their 
molecular structure or function (13). Classes A, C and D are serine-ß-lactamases 
which require an active site serine residue to catalyse the ring opening of the ß-
lactams and are mostly penicillininases or cephalosporinases. Class B enzymes, 
called metallo-ß-lactamases (MBLs), use one or two zinc ions in their active site for 
their activity and show a broader substrate profile as the serine-ß-enzymes. MBLs 
also hydrolyse carbapenems (e.g. imipenem) and penems and are not inhibited by 
the clavams commonly used to inhibit the serine-ß-lactamases (14). MBLs have now 
N
PhCH2CONH
S
CO2-
O
HN
PhCH2CONH
S
CO2
-
O O-
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become clinically extremely relevant and a lot of efforts have been put into the 
characterization of the MBLs in order to develop efficient inhibitors. 
1.3 Metallo- ß -Lactamases 
1.3.1 Emergence of MBLs 
The first MBL was isolated from Bacillus cereus 569/H/9 in 1966, where EDTA was 
shown to inhibit the cephalosporinase activity (15). As Bacillus cereus is a non-
pathogen organism and the isolate was the only example of these zinc-dependent 
enzymes, the discovery was only considered as a curiosity. In the early 80’s, an 
increased number of MBLs was isolated from many organisms even from 
pathogenes such as Stenotrophomonas maltophilia or Pseudomonas aeruginosa 
(16). More frightening was the identification of a gene coding for a MBL in Bacillus 
anthracis (17). Their fast dissemination could be explained by the location of their 
encoding genes on mobile DNA plasmids, which allow horizontal gene transfer (18). 
 
1.3.2 Characteristic of MBLs subclasses 
Combination of X-ray structure data and sequence alignments enabled the division of 
the MBLs into three subclasses (B1-B3) (19). The classification is based on both, the 
metal-ligands composition of the two binding sites, and their substrate profile. In the 
subclass B1, three His constitute the metal binding site 1 and one His, one Cys and 
one Asp form the metal binding site 2 as shown for the BcII enzyme from Bacillus 
cereus (Figure 1.2A). In subclass B2, only one His is replaced by one Asn in the site 
1, the rest of the active site residues being identical with those from subclass B1. 
Zinc-ß-lactamase CphA from Aeromonas hydrophilia is one of the representative 
MBLs of subclass B2 (Figure 1.2B). The same metal-binding residues are present in 
site 1 for subclass B3 compared to subclass B1, but the Cys from metal binding site 2 
is replaced by a His as illustrated in the case of the L1 enzyme from 
Stenotrophomonas maltophilia (Figure 1.2C). B1 and B3 enzymes generally exhibit a 
broad substrate profile, whereas the subclass B2 enzymes are carbapenem specific. 
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  A    B    C 
 
 A    B    C 
 
 
 
 
 
 
 
Figure 1.2: Active site views of Metallo-ß-lactamases BcII from Bacillus cereus (A), CphA 
from Aeromonas hydrophilia (B) and L1 from Stenotrophomonas maltophilia (C) created with 
the PyMOL program. The metal ligands are represented as stick models and the metals as 
spheres. The atom coloring scheme is blue for nitrogen, red for oxygen, orange for sulfur, 
fawn for zinc, and gray for carbon. The residue-numbering scheme is the standardized 
version from reference (20). 
 
1.3.3 The MBL fold 
Despite the low similarity of their amino acid sequences, all known MBLs revealed a 
αßßα fold composed by two central ß-sheets and five solvent-exposed α-helices 
(Figure 1.3). The N- and C- terminal domains, containing one ß-sheet and two α-
helices each, can be superimposed by a 180° turn around a central axis, suggesting 
that the structure is the result of gene duplication (21). The active site is located in a 
long channel between both domains. Residues from each binding site are distributed 
between the N- and C- terminal domains. The MBL fold together with the highly 
conserved metal binding site are the characteristics of the MBL superfamily (22, 23), 
which contains a wide range of proteins with diverse functions like glyoxylase II, aryl 
sulfatase, cAMP phosphodiesterases or CMP-N-acetyl neuraminic acid hydrolases 
(23, 24). Interestingly, an independent group within the MBL superfamily, involved in 
DNA repair (e.g. Arthemis) (25, 26), also contains the MBL fold, but its function 
remains unclear. 
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Figure 1.3: Ribbon representation of the BcII enzyme from Bacillus cereus 569/H/9 (Protein 
Data Bank, accession number 1BVT) created with the PyMOL program. BcII is a αß-
sandwich structure with α-helices on the external faces. The N-terminal domain includes a ß-
sheet made of seven ß-strands (in blue), three α-helices (in red) and two characteristic loops 
(i.e. substrate binding loop and 56-60 loop) (in grey). The C-terminal domain includes a ß-
sheet made of five ß-strands (in blue), two α-helices (in red) and one characteristic loop (i.e. 
174-185 loop) (in grey). The metal ions are represented as spheres (in violet). 
 
1.3.4 Catalytic mechanism of MBLs 
Although the active site of subclass B1 MBL is constituted of two metal binding sites 
(1), crystal structures of these enzymes were solved in complex with one and two 
Zn(II) ions (21, 27, 28). Furthermore the catalytic activity was shown to be dependent 
on the [Metal(II)]/[E] ratio. Indeed, BcII a well know representative of subclass B1 
MBL, is active with both one and two zinc ions in its active site which implies two 
different catalytic mechanisms (2). Similar conclusions were made for the CcrA 
enzyme of Bacteroides fragilis (3), which were later contradicted by another study 
demonstrating the positive cooperativity in metal binding, leading to the conclusion 
that only the di-Zn form of CcrA is relevant for the catalysis (29). Based on structural 
and kinetic data, two different catalytic mechanisms were proposed for the zinc-
enzyme BcII. In the monozinc-form, Cys168 is proposed to act as a proton acceptor 
C-Terminal 
Domain
N-Terminal 
Domain
174-185 loop
Substrate 
binding loop
55-66 loop6 0
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for the Zn(II)-bound water; thus allowing the nucleophilic attack at the ß-lactam 
carbonyl by the hydroxide ion which eventually leads to the amide bond fission. This 
fission might be facilitated through deprotonation of the tetrahedral intermediate by 
Asp90, which by generating a dianionic tetrahedral intermediate, donates the proton 
to the amine nitrogen (Figure 1.4) (30). In the di-zinc-form of BcII, Cys168 is not 
required to catalyse the reaction. Instead, the bridging hydroxide ion between the two 
metals directly attacks the ß-lactam-ring (3, 31).  
 
 
 
Figure 1.4: Catalytic mechanism of the ß-lactam hydrolysis by the mono-Zn enzyme BcII 
from Bacillus cereus 569/H/9 (30). Possible reversible formation of the tetrahedral 
intermediate and its deprotonation by Asp90. 
 
1.3.5 Flexibility/Dynamics at the active site of MBLs 
Although the metal binding amino acids are identical among the available crystal 
structures of subclass B1, great variability in the position and type of solvent ligands 
have been detected, even for the position of the residues interacting with the metals 
(27, 28, 32-38). Consequently, several studies were carried out to investigate the 
degree of flexibility around the metal binding sites, especially focusing on the BcII 
enzyme. To provide some information on the metal coordination nature, 
spectroscopic techniques such as perturbed angular correlation (PAC) or nuclear 
magnetic resonance (NMR) can be used. In both techniques Zn(II) could not be 
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used as a spectroscopic probe and was always replaced by catalytically active Cd(II) 
(33). Previous studies using PAC spectroscopy performed on BcII indicated that at 
low [Cd(II)]/[E] ratios the single metal ion was distributed between both binding sites 
(33). Combination of PAC and NMR data revealed a dynamic process at the metal 
binding sites, due to the supposed intramolecular exchange of the cadmium ion 
between the two available binding sites (11). Later, this intramolecular exchange was 
also suggested for the zinc-enzyme (39). 
 
1.3.6 MBL inhibition 
To date, a considerable number of small organic molecules have been tested for 
inhibition of the MBLs. A recent review by Heinz et al., 2004 has reviewed the 
different classes of reported MBL inhibitors (1): tricyclic natural products, 
trifluoromethyl alcohols and ketones, hydroxamic acids, mercaptocarboxylates, 
biphenyl tetrazoles, carbapenem and penicillin derivatives, cephamycins and 
moxalactam, thiols, cysteinyl peptides, inhibitors derived from single-domain antibody 
fragment elicited in the Camelidae, thioesters derivatives, phenazines from a 
Streptomyces, succinic acid derivatives, sulphonyl hydrazones, disulfides, thiol-
substituted penicillin inhibitor, degradation products of cephalosporins, captopril, 
thiomandelic acid. Recently benzohydroxamic acids (40) and pyridine carboxylates 
(41) were also identified as potential inhibitors of MBLs.  
Potent in-vitro MBL inhibitors such as succinic acid (42) and mercaptocarboxylic acid 
derivatives (38, 43) have also been reported, displaying some inhibition constants in 
the low nanomolar range. Most of the inhibition studies were performed using the di-
Zn forms of the MBLs, at the exception of CphA which was considered as a 
monozinc-enzyme (6). In most cases, crystal structures revealed that the MBL bound 
inhibitor replaces the zinc bound-water molecules and acts as new metal ligand (1). 
For instance, it was shown that the sulphur group of thiol-containing inhibitors is 
chelated by both metal ions in binuclear enzymes (38, 44). Moreover, the same 
inhibitor can have different binding modes among the three MBL subclasses as it was 
shown for the inhibitor D-Captopril (10, 44, 45). Inhibitors can also change the affinity 
of the enzymes for the metal ions; mononuclear enzymes can be dinuclear in 
presence of an inhibitor (9) or the single metal ion can be stabilized in one binding 
site of the enzyme (10). 
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1.4 Non-covalent interactions 
Weak reversible interactions between proteins, proteins and ligands or proteins and 
metal ions are involved in most of the biological processes such as in signal 
transduction pathways (e.g. binding of extra cellular signalling molecules to 
receptors), in DNA replication, in RNA and protein synthesis and in all metabolic 
pathways (e.g. substrate recognition by the enzymes). The reversibility of the 
interactions is a prerequisite for the correct regulation of many of these processes. 
These weak binding features are also required for the proper folding of proteins. 
There are four main types of non-covalent interactions: electrostatic, hydrophobic, 
hydrogen bonding and van-der-Waals interactions. The nature of binding differs by 
their strength, geometry and specificity (46). Table 1.1 summarises the different non-
covalent interactions together with typical values of binding energies. 
 
Table 1.1: Binding energies of the non-covalent interactions compared with those of the 
covalent interactions. 
 
Non-covalent Forces Binding energy (kJ/mol) 
electrostatic 42 
hydrogen bonding 8-21 
hydrophobic 4-8 
van der Waals 4 
Covalent bonds (C-C) 300 
 
 
1.4.1 Techniques for the study of non-covalent complexes 
Conventional methods 
There are several established methods that are used for the study of non-covalent 
macromolecular interactions: native gel electrophoresis, co-immunoprecipitation and 
two hybrid-screening techniques allow the identification of binding partners of weak 
complexes; gel permeation chromatography and analytical ultracentrifugation are 
used to determine the binding stoichiometry between the two associates in solution 
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whereas nuclear magnetic resonance (NMR) and X-ray crystallography deliver 
structural informations about the molecular interactions. Binding affinities can even 
be determined using surface plasmon resonance (SPR), circular dichroism (CD) 
spectroscopy, light scattering, UV and fluorescence spectroscopy, isothermal titration 
calorimetry (ITC) or radioactive and fluorescence labelling techniques. Most of these 
techniques are often time consuming, require high amounts of proteins and/or do not 
offer sufficient resolution to detect interactions between proteins and small 
compounds. 
 
Mass spectrometry as a tool for the detection of non-covalent complexes 
Since the development of Matrix Assisted Laser Desorption Ionization (MALDI) (47, 
48) and Electrospray Ionization (ESI) (49), two soft ionisation methods, mass 
spectrometry (MS) has become an indispensable tool for protein analysis. In fact, the 
mass of a large number of macromolecules, such as peptides (50), oligonucleotides 
(51), small compounds (52) and also proteins with high molecular weight (53) can be 
determined. The speed, specificity and sensitivity (atomole amounts) of MS analysis 
are great advantages compared to conventional methods. Mass spectrometry 
techniques have first been applied for peptide sequencing (54, 55); after protein 
digestion, peptides are fragmented by collision induced dissociation (CID) and the 
experimental mass values are then compared with calculated fragment ion mass 
values which are stored in a database to enable protein identification. Later, the 
method was used for the study of protein-protein complexes in native (56) or 
denaturing gel electrophoresis by analysis of their protein digestion pattern. In 
denaturing gels, the molecules are crosslinked before they are loaded on the gel 
(57). Furthermore, to identify and determine binding constants of small compounds 
interacting with proteins, bioaffinity based liquid-chromatography-mass spectrometry 
(LC-MS) screening methods have been used (58). The binding partners are eluted 
from the chromatographic columns containing the target proteins and submitted to 
LC-MS for identification and quantification.  
When “non-denaturing” (or “native”) conditions are used, mass spectrometry can be 
used for direct detection of non-covalent complexes. The groups of Ganem (59), 
Katta and Chait (60) were the pioneers of “native” mass spectrometry, demonstrating 
that weak interactions between proteins and ligands can survive the ionization 
process. Since then, many non-covalent complexes have been characterized using 
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“native” mass spectrometry including protein-protein- (61), protein-ligand- (62), 
protein-metal- (63) or protein-DNA- interactions (64). Most of these studies were 
performed using the electrospray as ionization technique. In contrast to MALDI, in 
ESI ions are generated directly from aqueous solutions under near physiological 
conditions, facilitating the detection of weak complexes. Further, the detection of 
unspecific cluster ions in mass spectra, normally hindering the correct evaluation of 
binding stoichiometries, is a major problem in MALDI-MS. These non-specific 
interactions might be formed in the gas–phase after the desorption process (65). 
 
1.4.2 Study of metalloproteins using “native” ESI-MS 
Metal-protein interactions 
Together with “native” ESI-MS, many other techniques can be used to study metal-
protein interactions. Atomic absorption spectroscopy (AAS) or inductively coupled 
plasma (ICP) with atomic emission spectroscopy (AES) or mass spectrometry (MS) 
detection allowed the determination of the metal content of metalloproteins. However 
they are unable to distinguish between the different metal-substituted species 
coexisting in solution. By combination of high pressure liquid chromatography (HPLC) 
using neutral pH elution conditions with ICP-MS and ESI-MS, metalloprotein isoforms 
such as metallothioneins can be separated and their metal stoichiometries can be 
determined (66). However, such techniques are mainly used for the study of 
metalloprotein isoforms already present in biological samples rather than for 
reconstituted metal-loaded species of purified proteins. The simultaneous detection 
of different metal-binding protein species can be easily performed by “native” ESI-
MS. Generally, the binding of metal ions to the corresponding protein is observed by 
monitoring the m/z shifts of the ion peaks in the ESI mass spectra of the apoprotein. 
When titrating the apoprotein (P) with increasing amounts of metal ions (L), the ion 
intensities of metal-loaded species (PLn) can be determined for each metal 
concentration. In 1990, Fenselau and coworkers were the first to apply “native” ESI-
MS to metalloproteins by investigating the metal binding mode of Zn(II) and Cd(II) 
ions to metallothioneins (67). Later, Ca(II)-calmodulin (68) and Zn(II)-peptides 
stoichiometries (69) were determined using the same approach. 
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Metalloprotein-inhibitor interactions 
“Native” ESI-MS is also a very useful tool for the direct detection of metalloprotein-
inhibitor complexes. The relative intensities between the free and the ligand-bound 
metalloprotein ions observed in the ESI spectra can be compared to determine the 
ligand binding affinity. Competitive binding experiments can be performed by adding 
equimolar amounts of several inhibitors to the target protein in solution. The relative 
abundance of a ligand-bound species measured by ESI-MS depends on the relative 
affinity between this species and all the other complexes present in solution. As 
illustrated in Figure 1.5, the relative abundance observed for inhibitor B is higher than 
the one observed for inhibitor A. It can therefore be concluded that inhibitor B has a 
higher affinity for the target protein compared to inhibitor A.  
 
 
 
 
Figure 1.5: General procedure for the determination of relative binding affinities of ligands 
(inhibitors A and B) observed by “native” ESI-MS. MP represented a metalloprotein. 
 
Cheng and coworkers applied this method for the screening of two small libraries (7 
and 18 inhibitors derived from para-substituted benzenesulfonamides) for the bovine 
carbonic anhydrase II (70) and later with larger peptide libraries (289 and 256 
compounds derived from 4-carboxybenzenesulfonamides) (71). Due to the 
complexity of the ESI mass spectrum, a high resolution ESI-mass spectrometer and 
tandem mass spectrometry (MSn) experiments were required for the correct 
identification of the inhibitors. Additionally, the relative ion intensities of the free 
m/z m/z
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ligands themselves in the low m/z range allowed to determine their relative binding 
affinities in solution. In complex compound mixtures, a mass analyser with high mass 
resolution, such as Fourier Transform Ion Cyclotron Resonance (FTICR), or the 
simplification of the mixture by a pre-separation step, is essential for the correct 
identification of the different inhibitors. To provide the absolute binding constant 
values, competitive binding experiments can be performed in presence of a ligand of 
known binding affinity to the target protein (72). Direct quantification of binding 
constants is also possible by scatchard plot analysis; here, the ion abundance of the 
bound and unbound species is monitored for increasing amounts of the selected 
inhibitor (73). 
 
1.5 ESI-MS 
Electrospray ionisation (ESI) mass spectrometry (MS) is one of the most prevalent 
techniques used for the study of non-covalent complexes (61). Together with the 
technical improvement of ESI sources and analysers, the number of published 
”native” ESI-MS studies has increased considerably during the last 15 years. 
 
1.5.1 Principle 
The generation of ions by the electrospray (ES) technique was first accomplished by 
Dole in the 1970´s. In this report, a solution of high-molecular weight polystyrene was 
sprayed at atmospheric pressure. Unfortunately, the mass of the produced ions could 
not be directly determined (74, 75). Later, the Fenn group was able to observe the 
ions generated from smaller molecules with a quadrupole analyser, which provided a 
better understanding of the processes occurring during electrospray formation. In 
1984, a mass spectrometer incorporating a highly sensitive electrospray ionisation 
source was designed (76, 77).  
The ionisation by ES starts with spraying of a dilute sample solution through a strong 
electric field, which finally leads to an effective ionisation of the dissolved analytes. 
The electric field is formed by a high voltage difference between a capillary needle 
(metal), where the solution is infused, and a counter electrode. Due to the induced 
electric forces, the solution starts to nebulise and, because of the polarity of the 
capillary, the molecules are ionized with the excess of positive or negative charges. 
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Later, the ions are beaconed through the orifice of the counter electrode and led into 
the mass spectrometer, where they can be separated according to their respective 
m/z ratios. Frequently the spray is pneumatically assisted with a concentric flow of an 
inert gas such as nitrogen to provide a better nebulisation. When the repulsion of 
similarly charged ions and the attraction of the counter electrode exceed the surface 
tension of the solution, the destabilised liquid forms a cone (“Taylor cone”) as 
schematised in Figure 1.6. 
 
 
Figure 1.6: Schematic representation of the electrospray ionisation process, resulting in the 
formation of the “Taylor cone” and small offspring charged droplets. 
 
At the end of the Taylor cone, the charged droplets are then emitted (liquid filament). 
The continuous evaporation of the solvent in the droplets progressively induces a 
diminution of its size. Thus, the charge density increases by a constant charge state 
of the droplet. When the radius of the droplet reaches a certain limit (Rayleigh 
stability limit), the repulsive Coulomb-forces exceed the surface tension forces of the 
liquid, which induces the explosion of the droplet into smaller offspring droplets. Two 
models have been proposed for the theory of the ion emission into the gas phase. 
The first one stipulates that successive explosions conduct to the formation of 
droplets, where only one ion is contained. The ion is then transferred into the gas 
phase by the evaporation of the solvent (74). The second theory postulates that when 
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the size of the droplets is relatively small, the field strength at the surface of the 
droplet is sufficiently strong to directly extract the ions from the droplet into the gas 
phase (78, 79). 
 
1.5.2 ESI ion source design 
Nano-electrospray 
In many applications, nanoliter flow rates (20-50 nl/min) are required, which can be 
obtained with a nano-electrospray (nanoESI) device. Wilm and Mann demonstrated 
that the thinner the spray capillary, the smaller are the droplets and the lower are the 
flow rates (80). In nanoESI, the generated spray is not assisted by pneumatic 
nebulisation. The droplet size obtained from nanoESI is less than 200 nm, i.e their 
volume is about 100 to 1000 times smaller than the droplets generated using 
conventional ESI. Consequently, the nanoESI sources enable the analysis of 
samples in high polarity solvents such as pure water; the effect of corona discharge 
is there minimized. Lower sample consumption and higher salt concentration 
tolerance can also be achieved as with conventional ESI. In fact, the smaller size of 
the droplets in nanoESI reduces the competition between salt and analytes on the 
surface of the droplet (81). 
 
Nano-electrospray from a chip 
For high sample throughput in nanoESI experiments, a silicon chip with 10 X 10 array 
of nanoESI spray nozzles (10 um ID X 30 um OD X 75 um length) was developed 
(82). Sample solutions are supplied from a pipette tip making contact with the back of 
the chip. High voltage is applied on the electrically conducting coating of the tip. A 
robotic device called NanoMate® provides the automated infusion of samples at low 
flow rates. It also includes the ESI Chip and a software for automatic chip handling 
(Figure 1.7).  
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Figure 1.7: Nanomate® system developed by Advion Biosciences for the automatic infusion 
of MS samples (A). The 100 nozzles containing ESI chip with a close-up on a single spray 
nozzle are represented. Picture was downloaded from http://www.advion.com/images/img-
newesichip.gif (B). Schematic representation of a conductive pipette tip making contact with 
the back of the Advion chip. Reproduced from the nanomate User’s manual (C)  
 
1.5.3 Atmospheric-Vacuum Interface 
Following the ionisation process at atmospheric pressure, the ions are guided 
through an atmospheric-vacuum interface before they reach the analyzer. The 
interface consists of i) an orifice through which the ions are introduced, ii) pumping 
stages to reduce the pressure and iii) ion optics to improve the ion transmission to 
the analyser. The vacuum interface also helps to complete the desolvation of the 
ions. In this region, under a pressure of 1-3 mbar, the accelerated ions collide with 
the residual gas molecules leading to the break-up of solvent clusters. The ion 
acceleration is produced by applying a voltage (cone voltage) between the sampling 
cone and the next extraction lens (extraction cone). Increase of the accelerating 
voltage (VC), higher internal energy is communicated to the ions through collision 
with gas molecules, which induces the dissociation of the weakest binding 
interactions. This process is also called collision induced dissociation (CID) (83). The 
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effect of the accelerating voltage can be used for the study of the stability of non-
covalent complexes (84). 
 
1.5.4 Analysers 
Time of Flight analyser 
The principle of a time of flight (ToF) analyser is to measure the time of the ions to 
traverse a field-free tube (Figure 1.8). Since all ions of the same charge receive the 
same kinetic energy prior to their entrance into the flight tube, the lighter ions arrive 
earlier than heavier ones at the detector. The time of flight of an ion varies with the 
square root of its mass-to-charge ratio (m/z). 
 
 
Figure 1.8: Schematic representation illustrating the principle of the time of flight (ToF) mass 
spectrometer. After acceleration through the electric field, the ions are separated in the flight 
tube according to their m/z ratios. 
 
Resolution of a ToF mass analyser 
The resolution of a ToF mass analyser is defined by the full width at half maximum 
(FWHM) of the peaks, m/∆mFWHM. ∆mFWHM is the width of a single peak at 50 % 
height. Thus, the increase of the tube length will increase the mass precision. 
Furthermore, the resolution of the ToF analyser can also be improved with a 
reflectron installed at the end of the tube. The reflectron is composed of series of 
metal rings, where increased voltages are applied. The kinetic energy distribution of 
ions with same m/z ratios can then be corrected. In fact, ions with high kinetic energy 
can penetrate deeper into the potential gradient and take longer to turn around 
compared to ions with lower kinetic energy. 
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Hybride Q-ToF mass analyzer 
Hybride mass analyses, which combines two mass analysers, are frequently used to 
perform tandem mass spectrometry. In the study of non-covalent complexes, a 
quadrupole analyser coupled with an orthogonal ToF analyser can be used (Figure 
1.9). A continuous ion beam from the quadrupole hits the entrance of the ToF 
analyser. Packets of ions are reaccelerated into the ToF in a direction orthogonal to 
the axis of introduction. The reacceleration of ions is possible by pulsed injection via 
the pusher. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9: Schematic representation of an ESI-Q-ToF (Q-ToF II of Micromass) used for the 
analysis of non-covalent complexes. The atmospheric vacuum interface is represented 
between the sample cone and the extraction cone of the instrument. 1 and 2 are the source 
and turbomolecular pumps, respectively.  
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1.6 Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) 
1.6.1 Development of HDX-MS 
More than 50 years ago, LinderstrØm-Lang and co-workers used hydrogen exchange 
experiments in order to prove that protein conformations protect the amide protons 
from being exchanged with hydrogens from the solvent (85). Protein structure and 
dynamics were also probed by using tritium labelling and radiation counting 
experiments (86). Ultraviolet spectroscopy and neutron diffraction have also been 
used to study the hydrogen/deuterium exchange (87, 88). At present, there are two 
main techniques used to monitor hydrogen exchanges in proteins, multi-dimensional 
nuclear magnetic resonance (NMR) (89, 90) and mass spectrometry (MS) (91). Both 
methods can provide the localisation of the exchanged amide proton and the 
determination of the exchange rates in specific regions of the protein. The NMR 
technique enables the assignment of hydrogen exchange rates to single amides in 
the protein, but the complete assignment of all amides is arduous and often not 
reached. Further, high protein amounts are required by NMR to follow correctly the 
HDX rates of the assigned amide protons.  
Alternatively, mass spectrometry can be used for the detection of deuterium uptake in 
peptides and proteins via the determination of their molecular masses. The 
advantages compared to NMR are multiple and include higher sensitivity, protein 
solubility (adapted for hydrophobic proteins) and no limitation to the size of the 
proteins. In 1991, Katta and Chait were the first to report the quantification of 
incorporated deuteriums into a protein using mass spectrometry (60). To measure 
the H/D exchange of localised regions of the target protein, the labelled 
macromolecule can be fragmented by proteolysis under isotopic quench conditions. 
Zhang and Smith combined protein fragmentation with HDX-MS using Fast-Atom-
Bombardment (FAB) as ionisation source (91). Johnson and Walsh then improved 
the amide coverage with the use of LC-ESI-MS to study the stability of the 
myoglobin-heme complex (92). Later, the major challenge facing the HDX technique 
was to prevent the back exchange of incorporated deuteriums to hydrogens during 
the sample preparation for the MS analysis (93). 
Matrix Assisted Laser Desorption Ionization (MALDI) is another ionisation technique, 
which can be used in combination with HDX. Although higher back exchange and 
lower sequence coverage is usually obtained compared to when using ESI-MS, the 
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absence of the HPLC step enables the data to be collected faster. The Komives 
group investigated the ligand binding sites in c-AMP-dependent protein kinase and in 
thrombin using HDX-MALDI-MS. Their HDX results were in good agreement with the 
X-ray data of the two proteins (94, 95). 
 
1.6.2 Theory of the H/D exchange 
The hydrogen/deuterium exchange acts on peptide amide bonds and can be both 
catalyzed by acids or bases. The rate constant for hydrogen exchange, kex can be 
expressed as the sum of the rate constants for acid (kH) and base (kOH) catalysed 
exchange, as indicated in the Equation 1.1. 
 
 
][][ −+ += OHkHkk OHHex    Equation 1.1 
    
 
Studies on H/D techniques using polyalanine as a model peptide indicated that kH 
and kOH have values of 41.7 and 1.2 × 1010 M-1 min-1 at 20 °C, respectively (96, 97). 
Isotopic exchange rates are pH and temperature dependent (97). The isotopic 
exchange rate, kex, for the model peptide polyalanine is shown in Figure 1.10 as a 
function of pH (98). The chemical exchange rate has been found to be the slowest at 
pH 2.3; further, the amide hydrogen exchange rate decreases 3-fold for each 10 °C. 
Additionally, adjacent amino acid side chains can also influence the exchange rate of 
a peptide amide proton by inductive and steric effects (97).  
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Figure 1.10: Rate constant for the isotopic exchange of hydrogen located on peptide amide 
linkages for a model polyalanine peptide presented as a function of pH (97).  
 
The presence of secondary and tertiary structures in proteins decreases considerably 
the H/D exchange rates. This structural impact can be quantified using the protection 
factor value which is defined as the ratio between the exchange rate constant of a 
specific peptide amide proton located in the unfolded protein and the exchange rate 
constant for the same proton in the folded protein. Many reports determine the H/D 
exchange rates of single amide protons for an unstructured peptide in order to obtain 
the protection factors for the same amide protons in folded peptides (99, 100). 
Secondary and tertiary structures can decrease the H/D exchange rate by seven 
orders of magnitude compared to adjacent side chains in folded proteins. 
Consequently, a large reduction in H/D exchange rate is an excellent indicator of 
conformational changes in proteins. 
Amide hydrogen exchange in folded proteins can essentially be explained by two 
different processes. The first one, described in Equation 1.2, reflects the hydrogen 
exchange on peptide bonds without the aid of structural changes, i.e for amide 
protons located on the surface or open channels within a folded protein (closed form). 
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Mcl (H) k f →  M cl (D)   Equation 1.2 
 
 
Mcl refers to the closed form of the macromolecule (M) and H and D stand for 
hydrogen and deuterium, respectively. The rate constant for the H/D exchange by 
this process is kf. 
 
The second process of H/D exchange can be explained in combination with protein 
dynamics. In general, H/D exchange rates are slower when amide protons are 
located far from the solvent-protein interface or when the protons are involved in 
intramolecular hydrogen bonding such as in α-helices or ß-sheet conformations. 
Shielded protons can only exchange with the solvent through local reversible 
unfolding-folding processes of small regions in the protein. Different models exist to 
explain these unfolding mechanisms. The “penetration model” postulates that the 
solvent enters the protein core through transiently formed channels and cavities 
(101). In the “local unfolding model”, small regions of a protein unfold cooperatively, 
which expose them to the solvent (99, 102). In both models, the hydrogen can then 
exchange with the solvent and can therefore be described by Equation 1.3. 
 
)()()()( DMDMHMHM clkopkopkcl clchop →←→→←         Equation 1.3 
 
Mcl and Mop refer to the closed and open forms of the macromolecule (M). Rate 
constants corresponding to the closure and the opening of the folded macromolecule 
are represented by kcl and kop, respectively, and the rate constant corresponding to 
the H/D exchange itself is represented by kch. In native proteins, kop » kcl together 
with two extremes situations referred to as EX1 and EX2 exchange mechanisms are 
usually described (103, 104). 
The observed H/D exchange rate (kobs) is the deuteration level measured as a 
function of time. For most proteins at neutral pH and in absence of denaturants is kcl 
» kch, which leads to the simplified expression of kobs given by Equation 1.4. This 
extreme value of kobs is also called the EX2 exchange mechanism. 
 
  THEORETICAL BACKGROUND 
 
36
 
chclopobs kkkk ×= )/(
   Equation 1.4 
 
where kop/kcl is the equilibrium between opened and closed form processes and kch is 
the exchange rate constant for the amide proton in the regions where the protein is 
unfolded (105, 106). Measuring kobs and calculating kch leads to the direct 
determination of kop/kcl which enables the access to the ∆G value for the protein 
unfolding processes for specific regions of proteins or for the entire molecule (107-
109). 
If the local unfolding events are much slower than the chemical reaction (kcl « kch), 
the kobs is only dependent on the rate of protein unfolding kop (110) as shown in 
Equation 1.5 and is referred to as the EX1 exchange mechanism. 
 
kobs = kop      Equation 1.5 
 
Generally the EX2 mechanism is preferred in native proteins, whereas the EX1 
became favoured when significant amount of chaotropic agents are present in the 
system. 
 
1.6.3 Measurement of H/D rates by mass spectrometry 
There are two main strategies to label a protein using D20, the continuous labeling or 
the pulse-labeling. In the latter method the protein is incubated for a period of time 
(usually 30 min) in presence of chaotropic reagents and a short pulse of deuterium is 
then introduced to the reaction mixture subsequently followed by a quenching step. 
This technique is often used to detect kinetic intermediates in order to elucidate 
protein folding and unfolding mechanisms (111). In the continuous labeling method, 
the native protein is exposed to deuterium at time t = 0 and the reaction is quenched 
at different times during a period of one to two hours. This labeling technique is 
required for the study of conformational properties in native proteins. In both 
methods, the isotopic exchange rates can be determined by the mass increased on 
the whole labeled protein or on specific labeled regions in the protein using mass 
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spectrometry. While mass measurements of the whole protein enable the study of 
global changes in the protein, fragment analysis can pinpoint the actual location of 
these structural changes. 
 
1.6.4 General procedure for HDX-MS experiments 
In the present study, continuous labeling was used to monitor the conformational 
changes of the protein of interest. The general procedure used for the determination 
of amide hydrogen exchange rates in intact proteins is illustrated in Figure 1.11. 
Generally, the reaction is initiated by the addition of an excess of D20 (10 fold) to the 
protein solution at physiological pH. After a number of exchange times, the reaction is 
quenched by rapidly decreasing both the temperature and the pH. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11: General procedure used for HDX exchange MS experiments. The protein is 
labeled using D2O buffer and left standing for a pre-defined period time. The H/D exchange is 
quenched by decreasing pH and temperature. For the determination of the total amount of 
incorporated deuteriums in the protein, the mass of the labeled protein is directly measured 
by MS. For the determination of incorporated deuteriums in localised regions of the protein, 
the labeled protein is fragmented by pepsin proteolysis prior to the detection of the peptic 
peptide fragment by MS. 
Protein
D2O exchange buffer
Labeled Protein
pH 2-3, 0°C
Labelling quenched
Local exchange informationGlobal exchange information
pH 2-3, 0°C
Pepsin digest
LC-ESI-MS or 
MALDI-MS
ESI-MS or 
MALDI-MS
Fragment deuterium level
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At pH 2.3 and 0 °C, the rate of the H/D reaction is significantly decreased. In case of 
the detection of global changes in the protein, the labeled macromolecule is then 
directly submitted to the mass spectrometer to minimize artifactual isotopic 
exchanges. For the localisation of structural changes, the labeled protein is first 
digested with an acid-stable protease, generally pepsin, which is added to the 
labeled protein and then submitted to the mass spectrometer for analysis. 
 
1.6.5 Pepsin digestion 
High pepsin concentration is generally added to the deuterated protein sample in 
order to speed up the digestion time, which is important to minimise the isotopic 
back-exchange. The ratio of protein:pepsin is often 1:1 (w/w). Pepsin is a protease 
with low specificity and usually produces many peptide fragments. The cleavage sites 
of pepsin can not be predicted with certainty, due to the possible cleavage at different 
residues both from the N-and C-terminal sides. The generation of many peptic 
peptides is necessary for a good sequence overlap in order to obtain a high 
sequence coverage. Presence of overlapping peptides can improve the structural 
resolution of the measurements to within 3-4 amino acids (112). Additionally, the 
structural resolution can also be optimised by using multiple acid stable proteases 
with different specificity (113). The use of a non-specific protease such as pepsin 
requires the sequencing of the product peptides and accurate peptide mass 
measurements. The sequencing of peptides is generally performed by tandem mass 
spectrometry experiments, which deliver the mass of several fragments originating 
from the same parent peptides. 
 
1.6.6 Loss of deuterium during sample preparation for MS analysis 
After labeling the protein using high amounts of D2O buffer, the concentration of D2O 
has to be decreased prior to digestion and MS analysis in order to avoid artificial 
deuterium incorporation through possible structural changes. This can be highly 
detrimental to the HDX experiments and lead to a major loss of structural information 
by uncontrolled back-exchange of the viable incorporated deuteriums with protons 
from the digestion buffer. This would then prompt to misleading conclusions since the 
distinction between deuterium not incorporated during kinetic analysis and those 
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back-exchanged during sample preparation is not possible anymore. Deuteriums 
located on the amino acid residue side chains and on the N- and C- terminus back-
exchanged too rapidly to be detected. Consequently, only the deuteriums located at 
the backbone amide positions will be detected by mass spectrometry. The back-
exchange rate constant of the amide bond deuterium can be drastically reduced by 
decreasing the pH to 2.3 and the temperature to 0 °C (96). Quantification of the back-
exchange can be achieved by measuring the loss of incorporated deuteriums from 
fully labelled protein peptide fragments. 10-20 % back-exchange can usually be 
achieved by improvement of the MS protocols (93). When a LC separation is used 
prior to MS analysis, the application of a cooling and desalting system is required in 
order to minimise the back-exchange during the separation of the peptic peptide 
fragments. The use of MALDI as ionisation method, requires a fast preparation and 
an efficient target cooling techniques to further reduce the potential back-exchange 
during the sample preparation on the MALDI target (114). 
 
1.6.7 Determination of hydrogen exchange rate constants 
Structural differences between proteins exposed to various conditions (addition of 
ligands, post-translational modifications, pH variation, etc…) can be detected by the 
analysis of the fragments (peptides) generated from the labeled protein at specific 
times. However several time points of the H/D exchange experiment are required to 
obtain complete information about the conformational changes in the protein. By 
fitting the time courses to mono, bi- or tri-exponential equations, a range of isotopic 
exchange rate constants at peptide bonds in one segment can be determined. 
Ideally, the exchange rate constant for every single peptide linkage in the segment 
should be determined. However in practice, the determined rate constants are often 
the averaged values of a set of real rate constants. 
 
1.6.8 HDX with MALDI-MS 
Matrix Assisted Laser Desorption Ionization (MALDI) has been shown to be a soft 
ionisation method for the mass spectrometric analysis of biomolecules such as 
proteins, peptides and oligonucleotides (50, 51). Mandel et al., 1998 have shown for 
the first time that MALDI can also be a powerful tool to monitor HDX experiments 
(115). Generally, the sample is co-crystallised with an excess of organic matrix on the 
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MALDI target and then is introduced into the high vacuum of the mass spectrometer. 
The matrix absorbs the energy of the laser light (λ = 355 nm) and then induces the 
desorption and ionisation process of the analytes. The ionised analytes are then 
accelerated through a high voltage region and separated based on their mass to 
charge ratio inside the analyser. In most cases, a time of flight analyser is coupled to 
the MALDI technique (see paragraph 1.5.4).  
In contrast to the ESI ionisation process, MALDI generates mainly single charge 
peptide ions [M+H]+, which reduces the number of peaks observed in the mass 
spectrum. Moreover, by generating multiply charged ions, ESI requires the LC 
system to be connected upstream to the mass spectrometer to reduce peak 
overlapping. Due to complex deuteration states possibly occurring in a single peptide, 
deuterated peptides show more peak overlap compared to the non-deuterated ones, 
which leads to additional complication in the peak assignments of the ESI mass 
spectra, emphasising even more the advantage of using MALDI over ESI ionization. 
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2 EXPERIMENTAL PROCEDURES 
2.1 Materials 
2.1.1 Substrates and Inhibitors 
Imipenem was a gift from Merck Sharp and Dohme (Haar, Germany). All tested 
inhibitors were provided by Benoît M. Liénard, Group of Prof. Christopher J. 
Schofield, Organic Chemistry Department, University of Oxford, UK. 
 
2.1.2 Reagents and Chemicals 
MALDI-matrix α-cyano-4-hydroxycinnamic acid (CCA), 5,5'-dithiobis-(2-nitrobenzoic 
acid) (DTNB), chelex-100 sodium form, metal ion salts (ZnCl2, CoCl2 and CdSO4) 
diaminoethanetetraacetic acid (EDTA), cesium iodide (CsI), sodium dodecyl sulphate 
(SDS), hydroxymethylaminomethane (TRIS) and dimethylsulfoxide (DMSO) were 
purchased from Sigma-Aldrich Chemical Co. (Steinheim, Germany). Trifluoroacetic 
acid (TFA), formic acid (FA), ammonium acetate (CH3COONH4), sodium chloride 
(NaCl) and ammonium hydroxide (NH4OH) were provided by Fluka (Neu-Ulm, 
Germany). Acetonitrile (MeCN) and methanol (MeOH) were obtained from Riedel-de 
Haën (Seelze, Germany). Deuterated water (D2O) (99.9 % deuterium) and 
deuterated sodium hydroxide NaOD (40 % in D2O) were obtained from Deutero 
GmbH (Kastellaun, Germany). Pepsin immobilized on cross-linked 6 % beaded 
agarose was obtained from Pierce (Rockford, UK). Mag-fura-2 (MF) was provided by 
Molecular Probes, (Eugene, Oregon, USA). Calibration mixture containing des-Arg1-
Bradykinin, Angiotensin I, Glu1-Fibrinopeptide B, ACTH 1-17, ACTH 18-39 was 
obtained by Applied Biosystems (Darmstadt, Germany). HEPES was purchased from 
Roth (Karlsruhe, Germany). Ammonium hydrogen carbonate (NH4HCO3) was 
provided by Merk (Darmstadt, Germany). Water was purified with a Millipore 
(Bedford, MA, USA) water purification system. Organic solvents were all of HPLC 
grade. All chemicals used were of analytical grade.  
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2.1.3 Membranes and columns 
The dialysis tubing (16 mm Ø) was provided by Servapor, Boehringer Ingelheim 
Bioproducts, (Heidelberg, Germany). The Microcon YM-10 (cut off = 10,000 Da) 
centrifugal filters and the ZipTipC18  columns were obtained by Millipore (Bedford, MA, 
USA). 
 
2.2 Methods 
2.2.1 Production and characterization of Enzymes and Apo-Enzymes 
Metallo-Enzymes 
The metallo-ß-lactamases BcII from Bacillus cereus 569/H/9, CphA from Aeromonas 
hydrophilia AE036 and L1 from Stenotrophomonas maltophilia were produced and 
purified as described in references (2, 116) and (117) respectively. The BcII 
preparation (2) was modified as follows: cells were grown at 37 °C in M9 minimal 
medium with 10 g/l of glucose and 1 g/l of NH4Cl. Expression was induced by adding 
1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) at an absorbance at 600 nm of 
0.6. After 16 h, cells were harvested by centrifugation, resuspended in MES buffer 
(10 mM, 1 mM ZnCl2, pH 6) and broken using French Press. Cytosolic proteins were 
separated from cells debris and were loaded to purification columns (2). 
Protein concentrations were determined with the following extinction coefficients: 
ε280(BcII) = 30,500 M-1 cm-1, ε280(CphA) = 38,000 M-1 cm-1 and ε280(L1) = 55,000 M-1 cm-1 
(per monomer). 
 
Apoenzymes 
The apoenzyme of BcII was prepared by three dialysis steps of the corresponding 
enzyme (2 mg/ml) using dialysis tubing against a 250-fold excess of 15 mM HEPES, 
pH 7.0 containing 20 mM EDTA (24 h with stirring at 4 °C). EDTA was removed by 
three dialysis steps against the same buffer containing 1 M NaCl followed by two 
steps without salt. Apo-CphA and apo-L1 were obtained by three dialysis steps of the 
corresponding enzymes (2.5 mg/ml and 8.5 mg/ml respectively) against a 250-fold 
excess of 15 mM HEPES, pH 6.5 containing 20 mM EDTA and 0.15 mM NaCl. EDTA 
was removed by three dialysis steps against the same buffer containing 1M NaCl 
followed by two steps with 0.15 M NaCl and a last step without salt. All buffer 
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solutions were prepared in bidistilled water extensively stirred with Chelex in order to 
minimize zinc ion contamination. The final concentrations of apoBcII and apoCphA 
were determined using Ellman´s reagent: 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) 
quantifying the free sulfhydryl groups in the protein at an extinction coefficient of 
ε412(DTNB) = 13,600 M-1 cm-1. 
 
2.2.2 Quantitation of sulfhydryl groups using Ellman´s reagent 
Desalting procedures can affect the sulfhydryl groups (cysteins) content in proteins 
by air oxidation. Therefore it was necessary to determine the exact active apoprotein 
concentration by quantifying the free sulfhydryl groups in the protein, since the 
number of cysteine residues in the protein is known (BcII and CphA contain only one 
cyteine residue). By addition of 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) to the 
protein solution at pH 8, thiophenol anions are produced, where their concentration 
can be determined at a wavelength of 412 nm (ε412(DTNB) = 13,600 M-1 cm-1). In 
presence of an excess of DTNB, the amount of produced thiolphenol anions is 
dependent on the free sulfhydryl groups in the protein. 
The reaction mixture was composed of 300 µM of DTNB and 10-50 µM protein 
solution in denaturing buffer (0.1 M TRIS, 1mM EDTA and 1% SDS, pH 8) at 22°C. 
 
2.2.3 Determination of Metal ion Affinities 
The dissociation constants for a first and second metal ion (KD1 and KD2 respectively) 
bound to apoenzymes (E) were determined in competition titration experiments with 
the chromophoric metal(2+)-chelator Mag-fura-2 (MF). The metal-free Mag-fura-2 (MF) 
has its absorption maximum at 363 nm and the metal-loaded Mag-fura-2 (Me-MF) at 
335 nm (118). The dissociation constants of Zn-MF and Cd-MF and the absorption 
coefficient of MF at 363 nm were determined under the same conditions as in the 
competition titrations described below and resulted in KZn-MF = 9.1 nM, KCd-MF = 5.6 
nM and ε363(MF) = 28500 M-1cm-1. Their values were used to calculate the dissociation 
constants of metal ions bound to the apoenzymes.  
For the competition titrations experiments, a 1 ml solution of 3 µM of metal indicator 
and 3 µM of apoenzyme in 15 mM HEPES, pH 7 at 22 °C was titrated with a stock 
solution of 255 µM ZnCl2 or 255 µM CdSO4. In presence of inhibitors, the 1 ml 
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solution contained also 6 µM of (R,S)-thiomandelate or 100 µM of D-captopril before 
titration with the metal ions. The total absorbance at 363 nm (Atotal) corresponding to 
the sum of MF and Me-MF can be followed for each titration step (2 µl) according to 
Equation 2.1 using a Lambda 9 spectrophotometer (Perkin-Elmer instruments) 
equipped with thermostatically controlled cells. 
 
Atotal = εMF[MF]+ εMe−MF[Me − MF]            Equation 2.1 
 
 
where Atotal is a function of the added volume of a metal ion stock solution [Me]stock to 
a defined starting volume (1ml).  
 
For numerical data analysis the program Chemsim was used calculating absorbance 
values for each titration step according to equation 2.1. For these calculations the 
laws of mass action (Equations 2.2-2.4) and the equations of mass conservation are 
used. 
 
MF + Me2+ K (Me−MF )← →    Me − MF  KMe−MF =
[Me2+][MF ]
[Me − MF ]  Equation 2.2 
 
E + Me2+ KD1← →   Me − E   KD1 =
[Me2+ ][E ]
[Me − E]   Equation 2.3 
 
Me − E + Me2+ KD 2← →   Me2 − E   KD2 =
[Me2+][Me − E]
[Me2 − E]
 Equation 2.4 
 
 
 
For data evaluation of competition experiments εMF, KMe-MF, starting volume and 
[Me]stock were constrained. In a least squares procedure KD1, KD2, [E]start and εMe-MF 
were simultaneously fitted and determined as described in (2). 
 
The effect of the inhibitors on metal ion affinities of the different enzymes can be 
expressed in terms of variations in KD1 and KD2. In presence of inhibitors (I), two 
additional equations were taken in account, representing the formation of 1:1 
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(Equation 2.5) and 2:1 inhibitor-metal complexes (Equation 2.6) in the case of (R,S)-
thiomandelate and the formation of 1:1 complexes (Equation 2.5) in the case of D-
captopril. 
 
MeIIMe ↔++2
   ][
]][[ 2
MeI
IMeK MeI
+
=
  Equation 2.5 
 
 
2MeIIMeI ↔+
   ][
]][[
2
2 MeI
MeIIKMeI =
  Equation 2.6 
 
 
In titration experiments with the inhibitors D-captopril and (R,S)-thiomandelate 
Equation 2.5 or Equations 2.5 and 2.6 were included into the binding models, 
respectively. When competition experiments were carried out with enzymes, KMeI and 
KMeI2 were fixed to the experimentally determined values. 
 
2.2.4 Determination of inhibition constants 
Inhibition constants of the inhibitors were determined assuming competitive inhibition. 
Imipenem hydrolysis was followed by monitoring the change in absorbance at 300 
nm (∆ε300= 9000 M-1 cm-1) in 15 mM HEPES, pH 7 at 24 °C using a Lambda 9 
spectrophotometer (Perkin-Elmer instruments) equipped with thermostatically 
controlled cells. The final BcII enzyme concentration was 10 nM. The substrate 
concentration (S) was 160 µM and equal to the Michaelis Menten constant value (KM) 
of the enzyme for imipenem. The inhibitors were dissolved in 4-10 % DMSO, 15 mM 
HEPES pH 7 at 1-2 mg/ml and then diluted to the final concentration (I). Two different 
inhibitor concentrations were used to determine KI values using the following 
Equation 2.7 for competitive inhibition: 
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where vo corresponds to the initial rate of hydrolysis in absence of inhibitor and vi the 
initial rate of hydrolysis in presence of inhibitor. 
 
2.2.5 Preparation of samples for “native”- ESI-MS 
Desalting procedure of enzymes 
Prior to analysis, all proteins were desalted using Microcon YM-10 (cut off = 10,000 
Da) centrifugal filters in 15 mM ammonium acetate (pH 7.5). Seven 
dilution/concentration steps were performed at 4 °C and 14,000 g. Enzymes were 
diluted in 15 mM ammonium acetate buffer to a final concentration of 15 µM. 
 
Metal binding experiments 
Zinc and cadmium enzymes were prepared at room temperature, by adding a volume 
of 1-10 µl of 100 µM ZnCl2 or of 100 µM CdSO4 to 15 µM apoenzyme BcII dissolved 
in 15mM CH3COONH4 (pH 7.5) to obtain [Me2+]:[E] ratios ranging between 0.3 and 2. 
 
Inhibitor binding experiments 
100 mM inhibitor stock solutions were prepared with ethanol. Subsequent dilutions to 
final concentration were done with 15 mM ammonium acetate and the pH was 
adjusted to 7.5. Unless otherwise stated, for the inhibitor binding experiments each 
metalloenzyme was mixed with 1.3 molar equivalents inhibitor to metalloenzyme at 
room temperature prior to mass analysis. 
 
2.2.6  “Native”-ESI-MS analysis 
All sample mixtures were analysed using an ESI-Q-TOF mass spectrometer (Q-
TOFmicro Micromass, Altrincham, UK) interfaced with a NanoMate chip-based nano-
ESI source (Advion Biosciences, Ithaca, NY, USA). Typically a spraying voltage of 
1.68 kV and a sample pressure of 0.25 psi were applied. The instrument was 
equipped with a standard Z-spray source block. Each well was loaded with 5 µl 
sample and was infused to the mass spectrometer. The estimated flow rate was ca. 
100 nL/min. Clusters of Cs(n+1)In (1mg/ml CsI in 100 % methanol) were used for 
calibration. Calibration and sample acquisitions were performed in the positive ion 
mode in the mass range of m/z 500 – 5000. Operating conditions for the Q-TOF 
mass spectrometer were as followed: sample cone voltage (varied) between 15 to 
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200 V, source temperature 20 °C. Acquisition and scan time were 2 min and 1 s, 
respectively. The pressure at the interface between the atmospheric source and the 
high vacuum region was fixed at 6.7 mbar (measured with the roughing pump Pirani 
gauge) by throttling the pumping line using an Edwards Speedivalve to provide 
collisional cooling. Data were smoothed with the Savitzky Golay method (smooth 
windows: 20, number of smooth: 4) the background subtracted and the masses 
finally calculated by centering. The standard deviation reported for all the calculated 
masses represents the precision of the mass calculation from m/z values reported 
from the ESI mass spectrum. All data were processed using MassLynx software 
versions 4.0 and 3.5. 
 
2.2.7 Preparation of samples for HDX-MS 
Metal binding experiments 
Zn1 and Zn2-BcII solutions were prepared by adding 0.7 and 2.3 equivalents of ZnCl2 
to the apoprotein, respectively. Cd1 and Cd2-BcII solutions were prepared by adding 
0.9 and 6.6 equivalents to the apoprotein, respectively. Final metal-substituted 
protein and apoprotein stock solutions were 150 µM in 15 mM HEPES pH 7. 
 
Inhibitor binding experiments 
The inhibitor was dissolved in ethanol at 60 mM, and diluted in 15 mM HEPES pH 
7.5. For all HDX experiments, 400 µM of the inhibitor were added to the protein stock 
solution. 
 
2.2.8 Pepsin digestion 
15 µM of apoenzyme in HEPES 15 mM pH 7 (10 µl) was diluted 1:11 with 0.1 % tri-
fluoro acetic acid (TFA) solution to decrease the pH to 2.3. Protein digestion was 
performed by adding 30 µl of pepsin bead slurry (Pierce, Rockford, UK) (washed 4 
times prior to use with 450 ml of 0.1 % TFA at 4°C) and incubated on ice for 10 min 
with occasional mixing. The resulting peptides were separated from the pepsin beads 
by centrifugation for 20 sec at 14.000 g at 4 °C. To desalt the sample 10 µl of 
digestion was loaded on a ZipTipC18 (Millipore Corp., Billerica, MA, USA) rinced with 
0.1 % TFA. Subsequently the peptides were eluted with 1 µl of α-cyano-4-
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hydroxycinnamic acid matrix solution (5 mg/ml CCA in acetonitrile/ethanol/TFA 
20/80/0.1) onto the MALDI plate and dried under compressed air stream. 
 
2.2.9 Assignment of peptic peptides 
Porcine pepsin is a non-specific acidic endopeptidase with broad substrate 
specificity. Therefore high mass accuracy and/or MS/MS sequencing are essential for 
the identification of pepsin-digested peptides. First, the mass of each measured 
peptide was verified using the Paws program (download free from Genomic Solutions 
Inc: http://bioinformatics.genomicsolutions.com/paws.html). Paws is a bioinformatic 
tool which permits the mapping of the measured peptides to the protein sequence of 
interest. In most of the cases, two or three theoretical peptides were found to fit with 
the mass of a detected peptide by assuming a mass accuracy of ≤ 20 ppm. In a 
second step, MS/MS was performed for each measured peptide and the resulting 
fragments were compared manually with the MS/MS fragments of the possible 
theoretical peptides to identify the peptides. 
 
2.2.10 Hydrogen deuterium exchange (HDX) experiments 
In-exchange experiments 
For H/D exchange experiments, 1µl of 150 µM apo-BcII or metal-substituted BcII 
stock solution was incubated 1: 10 with deuterated buffer (D20, 15 mM HEPES, pH 7, 
not corrected for isotope effects) at 22 °C. Deuterium labelling times varied between 
50 and 5900 sec. Each in-exchange reaction was stopped by addition of 100 µl of 0.1 
% TFA on ice decreasing the pH to 2.3. The pepsin digestion and analysis of peptic-
peptides were performed as described above for the non-deuterated digest. After 
spotting the deuterated digestion:matrix solution on the MALDI target, each 
exchange experiment was immediately measured by MALDI-MS with less than 1 min 
delay. All solutions and ZipTips were kept cold (on ice) before use. The MALDI plate 
was kept at room temperature in order to prevent condensation of water on the plate. 
All experiments were repeated in triplicate. 
 
Back-exchange control experiments 
Fully deuterated sample m(100%) was prepared by incubating 10 µl of pepsin digested 
apoBcII (15 µM) in deuterated buffer (D20, 15 mM HEPES, pH 7 not corrected for 
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isotope effects) for 72 hours at 22 °C. Quenching and sample analysis were 
performed as described above. 
 
2.2.11 Determination of deuterium content 
The centroid mass of each isotope cluster was calculated using the MagTran 
software (119) by labelling the left side of the lowest deuterated peak and the right 
side of the highest deuterated peak. The deuterium in-exchange of amide groups 
(%D) of the peptic peptides was determined for each incubation time in D20 using 
Equation 2.8. m(t) is the observed centroid mass of the deuterated peptide for each 
in-exchange time, and m(0%) corresponds to the non-deuterated mass of the 
corresponding peptide. During sample preparation and transfer to the MALDI target, 
back exchange of incorporated deuteriums to hydrogens takes usually place. 
Therefore the experimental data were corrected for this back exchange using the 
experimentally obtained centroid mass of fully deuterated peptide m(100%) after back 
exchange as the 100 % value (91). 
 
%100*)(
)(
%
%)0(%)100(
%)0()(
mm
mm
D t
−
−
=
                         Equation 2.8 
 
 
For data representation the experimentally obtained values were further processed. 
From the experimentally determined masses, the hypothetical values for 100 % D2O 
in the incubation buffer were calculated. For the mononuclear samples, metal ion 
addition corrections for apo-enzyme content were introduced. Masses for Zn1-BcII 
were calculated from the experimentally obtained centroid masses of Zn0.7-BcII and 
apo-BcII according to m(Zn1-BcII) = 1.428[m(Zn0.7-BcII) – 0.3m(apo-BcII)]. Masses 
for Cd1-BcII were obtained from m(Cd1BcII) = 1.11[m(Cd0.9-BcII) – 0.1m(apo-BcII)]. 
 
2.2.12 Evaluation of HDX kinetics 
All the deuteration versus time curves obtained can be described by mono-
exponential curves. Equation 2.11 was used for fitting. A rapid HDX phase preceded 
the kinetic traces obtained for almost all the peptide fragments investigated. Since no 
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indication for the underlying rate constants can be derived from the data used, the 
amplitude of this phase is considered as a starting value of the fitted time course 
different from zero (%D0) in Equation 2.9. Fitting of Equation 2.9. to the data resulted 
in %D0, the rate constant k, and the amplitude of the process observed (%Dt). 
 
 
%D(t) = %D0 + %Dt (1− e−kt )             Equation 2.9 
 
 
2.2.13 MALDI-MS analysis 
Mass spectrometric analysis were performed using a 4800 MALDI TOF/TOFTM mass 
analyser (Applied Biosystems, Darmstadt, Germany) equipped with a 200-Hz 
Nd:YAG-Laser (λ = 355 nm, 3 to 7 ns pulse width). MS data were acquired in the 
positive ion reflectron mode with 470-ns delayed extraction, accumulating 500 laser 
shots using the 4000 Series ExplorerTM Remote Access Client software (version 
3.5.1). A calibration mixture (Applied Biosystems) containing des-Arg1-Bradykinin 
[m/z 904.4681], Angiotensin I [m/z 1296.6853], Glu1-Fibrinopeptide B [m/z 
1570.6774], ACTH 1-17 [m/z 2093.0867], ACTH 18-39 [m/z 2465.1989] was used for 
external calibration. Tandem mass spectrometry (post source decay with post 
acceleration) was performed for the sequencing of all detected peptic-peptides; no 
additional collision gas was used. For MS/MS measurements, the acceleration 
voltage was 8 kV, 4000 laser shots were accumulated for each MS/MS spectrum. 
 
2.2.14 Circular Dichroism Spectroscopy 
Circular dichroism spectra were recorded with a Jasco J740 at 20 °C. The CD 
spectra were recorded in 5 mM HEPES pH 7.0 at a protein concentration of 5 µM in 
cuvettes with 1 mm light path. Due to a strong background signal the useful spectral 
range did not reach below 200 nm in the far UV region. Three spectral scans with a 
resolution of 1 nm were accumulated and a binary smoothing function for noise 
reduction was applied after subtraction of the blank spectrum obtained for the buffer. 
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3 METAL AND INHIBITOR BINDING STUDIES using „NATIVE“-ESI-MS and UV 
SPECTROSCOPY: RESULTS 
3.1 Importance of the buffer system for the measurement of metal-protein 
complexes by ESI-MS 
The analysis of metal-protein complexes using ESI-MS requires the conservation of 
the non-covalent interactions existing in solution. Therefore, different buffer systems, 
compatible with the ionisation process by electrospray, were tested on the binuclear 
zinc enzyme BcII (Zn2-BcII). The metalloprotein was first measured in an organic 
solvent (methanol acidified with formic acid, representing denaturing conditions) used 
for routine analysis of proteins by ESI-MS and later in volatile and aqueous buffers 
such as ammonium acetate and ammonium bicarbonate at neutral pH, i.e “native” 
conditions. 
Figure 3.1A and 3.1B show the ESI mass spectra of Zn2:BcII in methanol/0.2% formic 
acid and in aqueous ammonium acetate (pH 7.5), respectively. When Zn2-BcII was 
measured in the organic solvent, the corresponding spectrum displayed a number of 
ions carrying a high number of charges ranging between + 16 and + 32 with a broad 
charge states distribution at low m/z values (m/z between 800 and 1600). The 
determination of the deconvoluted mass for BcII in denaturing conditions (24960 ± 
0.6 Da) revealed the loss of its two Zn(II) ions. In fact, the observed broad distribution 
of high charge states is typical for partially or fully unfolded proteins (120). When Zn2-
BcII was dissolved in ammonium acetate-buffer, the ions carried a lower number of 
charges ranging between + 8 and + 10 at m/z values between 2500 and 3100. A 
deconvoluted mass of 25087 ± 0.2 Da was calculated which corresponds to the fully 
zinc-loaded enzyme Zn2:BcII. The narrow distribution of low charge states is 
consistent with a “native” conformation of the protein in solution (120). Similar results 
were obtained when Zn2-BcII was dissolved in ammonium bicarbonate (pH 7.5). 
Thus, for the following metal titration experiments monitored by ESI-MS, the metal-
substituted proteins were dissolved in aqueous buffer in order to preserve the metal-
protein complex in solution. 
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Figure 3.1: Influence of the solvent on the charge state repartition of the BcII MBL. ESI mass 
spectra of the binuclear zinc enzyme BcII (15 µM) measured in methanol / 0.2 % formic acid 
(A) and in 15 mM ammonium acetate (pH 7.5) (B). Pressure at interface: 6.7 mbar, sample 
cone voltage: 100 V. The number of charges for the most relevant ions is specified in the 
figure. 
 
3.2 Metal binding studies monitored using ESI-MS 
To probe the zinc, cadmium and cobalt binding stoichiometry of the BcII enzyme, the 
addition of various concentrations of metal ions to the apoenzyme BcII was 
monitored by ESI-MS. The relative peak intensities of all the distinct protein species 
at different metal/apoenzyme ratios can then be compared. 
 
3.2.1 Detection of the metal - protein complex by ESI-MS 
In order for the results to have the potential to be biologically significant, the relative 
intensities displayed by the different protein species on the ESI mass spectra have to 
reflect exactly the distribution of these species in solution. Consequently, control 
experiments should be carried out in order to verify that certain protein structures or 
complexes are neither advantaged nor discriminated during the 
ionisation/desolvation process or later during their transfer through the interface of 
the instrument. The zinc titration of BcII was used for the validation of the method. 
ESI mass spectra (charge state z = 9 and z = 10) obtained by incubation of apo-BcII 
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with varying concentrations of ZnSO4 are shown in Figure 3.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: ESI mass spectra resulting from the incubation of apo-BcII (11.7 µM in 15 mM 
ammonium bicarbonate, pH 7) with different concentrations of Zn(II) ions (5 to 30 µM). The 
first recorded ESI mass spectrum corresponds to the apoenzyme just after the desalting 
procedure. (*) represented the salt adducts. The ions carrying the charges + 9 and + 10 are 
representated in the mass spectra. Experiments were carried out at sample cone voltage 200 
V, pressure at interface 6.7 mbar. 
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In general, for titration methods monitored with ESI-MS it is assumed that the 
concentrations in solution of protein (P), ligand (L) and complex (PL) are proportional 
to the observed intensities (I) in the mass spectrometer. This can be expressed by 
equations 3.1 and 3.2, where the proportionality constants tP and tPL represent the 
transfer coefficient of P and PL, respectively. In the present work, only the intensities 
of PL and P were investigated. 
 
PP ItP ∗=][       Equation 3.1 
 
PLPL ItPL *][ =      Equation 3.2 
 
 
To ensure that the different protein species exhibit the same ionization efficiencies, 
equal amounts of the different protein forms can be mixed together and the ratio of 
intensities of the different species can deliver the ratio of the species transfert 
coefficient. The BcII zinc titration (Figure 3.2) reveals that at low [Zn2+]/[apoprotein] 
ratios, three protein species with identical charge state can be detected with a 
respective mass difference of 63.4 Da between the successive protein species 
corresponding to the binding of one zinc ion minus two protons. In this case, it was 
not possible to prepare the stock solutions, where only one BcII protein species 
occured and consequently no relative ionization efficiencies could be determined 
independently. 
However, when L is much smaller than P (e.g. the binding of metal ion to protein) the 
transfert coefficients are close to equal and the intensity ratio of IPL/Ip is equal to the 
concentration ratio of [PL]/[L] in solution
 
(121). Therefore, in the following titration 
experiments it was assumed that apo, Zn1 and Zn2 species exhibit the same 
ionization efficiencies. 
Furthemore the variation of the sample cone voltage (VC) can assess whether the 
protein species are abnormally represented on the mass spectrum, due to the 
possible dissociation via gas phase collisions at the atmospheric-vacuum interface 
(84). During all the titration experiments, the variation of the cone voltage from 30 to 
200 V did not change the relative intensities of the protein species detected in the 
mass spectrum (data not shown). Therefore a high cone voltage was used for the 
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titration experiments to allow efficient ion desolvation and therefore a better mass 
accuracy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3: ESI mass spectra showing the result of the incubation of apo-BcII (11.7 µM in 15 
mM ammonium bicarbonate, pH 7) with different concentrations of Cd(II) ions in solution (6 to 
45 µM). The first recorded ESI mass spectrum corresponds to the apoenzyme just after the 
desalting procedure. (*) represented the salt adducts. The ions carrying the charges + 9 and 
+ 10 are representated in the mass spectra. Experiments were carried out at sample cone 
voltage 200 V, pressure at interface 6.7 mbar. 
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3.2.2 Determination of the metal binding mode with ESI-MS 
Table 3.1 summarises the relative peak intensities of the different protein species 
extracted from the ESI mass spectra of the zinc and cadmium titrations of BcII 
(Figure 3.2 and 3.3, respectively) as well as for the cobalt titration of BcII presented in 
appendix 1.  
At low [Cd2+]/[apoprotein] ratios, only the signals for the apoenzyme and the Cd1-BcII 
species are observed. At [Cd2+]/[apoprotein] ratios > 1, the Cd2-BcII species becomes 
the major signal in the ESI mass spectra. The results indicate that the active site of 
BcII accepts sequentially two Cd(II) ions, suggesting a negative cooperativity in metal 
binding. 
Zinc and cobalt showed a different binding behaviour; Me2-BcII species are 
monitored already at low [Me2+]/[apoprotein] ratios, which can be explained by 
positive cooperativity of metal ion binding which means that the dissociation constant 
for the binding of the second metal ion is lower than the one for the binding of the first 
metal ion to the protein (KD2 (Equation 3.4) < KD1 (Equation 3.3)). 
 
E + Me2+ KD1← →   Me − E   KD1 =
[Me2+ ][E ]
[Me − E]    Equation 3.3 
 
Me − E + Me2+ KD 2← →   Me2 − E   KD2 =
[Me2+][Me − E]
[Me2 − E]
  Equation 3.4
 
 
The absolute values of the dissociation constants could not be measured accurately 
using this technique, but the ratio of both constants could be determined from the 
relative intensities of the apoenzyme and the metal-loaded BcII species according to 
Equation 3.5, which is derived from Equations 3.3 and 3.4. 
 
[ ][ ]
[ ]22
2
2
1
EMe
EEMe
K
K
D
D
−
−
=
    Equation 3.5 
 
 
Table 3.1 shows that at different zinc concentrations the determined KD1/KD2 values 
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are > 1, which is consistent with positive cooperativity for zinc binding to BcII. The 
ratios KD1/KD2 obtained for the cobalt titration are close to 1.  
 
Table 3.1: Relative abundances (%) (peak intensities of ions carrying the charge + 9 and + 
10) of the different BcII complex species measured by ESI-MS during zinc, cadmium and 
cobalt titrations. The KD1/KD2 ratios are calculated from the relative abundances of metal-free 
and metal-loaded enzyme species according to Equation 3.5. The apo-BcII concentration 
was estimated to be 11.7 µM. 
 
 
KD1/KD2
E Zn1-E Zn2-E
61.5 18 20.5 3.9
39 19 42 4.5
24 22 54 2.7
9.5 14.5 76 3.5
/ / 100
E Cd1-E Cd2-E CdZn-E
60 40 / /
11 89 / /
/ 70 30 /
/ 19 61.5 19.5
/ 24 57 19
/ / 75 25
E Co1-E Co2-E
56 26.5 17.5 1.4
31 28 41 1.6
26 27 47 1.7
15 22 63 1.9
5 20 95 1.2
/ / 100
Co(II)
2.5
30
5
10
15
20
18
24
30
45
30
Cd(II)
6
12
5
10
12
14
on the ESI mass spectrum (%)
Relative peak intensities 
[Me]tot (µm)
Zn(II)
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3.3 Inhibitor binding studies performed by ESI-MS 
3.3.1 Development/validation of the native ESI-MS technique for the screening 
of MBL inhibitors 
The affinity of a number of mercaptocarboxylate compounds (Figure 3.4) towards the 
Zn2-BcII enzyme was investigated by “native” ESI-MS and was compared with those 
previously obtained by UV spectroscopy techniques (43). The affinity of the inhibitors 
was investigated by measuring the relative abundance of the Zn2-BcII-inhibitor 
complex compared to the free-inhibitor Zn2-BcII complex in the ESI mass spectra. 
Since the inhibitors have similar molecular masses, the comparison of the inhibitor 
affinities was performed from MS spectra containing a single inhibitor. Prior to run the 
first set of experiments, instrumental parameters for the detection of the metallo-
enzyme-inhibitor complexes were first optimized. It was assumed that the different 
protein species reflect identical ionization efficiencies, as the mass of the ligand is 
much smaller than that of the protein. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Mercaptocarboxylate compounds used in the screening for MBL inhibitors by 
nano-ESI-MS: Thiosalicylic acid (1), 4-mercaptobenzoic acid (2), benzylmercaptan (3), (R,S)-
thiomandelic acid (4) and mandelic acid (5). 
 
Influence of the cone voltage on the detection of metalloprotein-inhibitor 
complexes 
Due to the possible dissociation of the non-covalent complexes in the interface of the 
instrument, the stability of the Zn2-BcII-inhibitor complexes was investigated at 
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different cone voltages by ESI-MS. Figure 3.5 shows the ESI mass spectra (charge 
state z = 10 and z = 9) obtained after incubation of Zn2-BcII with 1.3 molar 
equivalents of thiosalicylate measured at different cone voltages. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: Influence of the cone voltage (VC) on the stability of the Zn2-BcII-thiosalicylate 
complex as observed by ESI-MS. Zn2-BcII (15 µM) incubated with 1.3 molar equivalents of 
thiosalicylic acid at sample cone voltage  120 V (A), 70 V (B), 50 V (C) and 20 V (D). All 
experiments were performed in ammonium acetate buffer (pH 7.5) with a pressure at the 
interface of 6.7 mbar. The ions carrying the charges + 9 and + 10 are represented in the 
mass spectra. Metalloenzyme and metalloenzyme-inhibitor-complex are represented by 
circle and cresent, respectively. 
 
The binding of one molecule of thiosalicylate to Zn2-BcII led to a mass increase of 
154 Da; the charge state of the inhibited state is identical to the non-inhibited state. 
The results of the experiments indicated that the sample cone voltage dramatically 
influences the stability of the Zn2-BcII-thiosalicylate complex (Figure 3.5). By 
increasing the cone voltage from 20 to 120 V, the peak intensity of the Zn2-BcII-
inhibitor complex decreased related to the peak corresponding to the Zn2-BcII 
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complex and finally disappeared at 120 V (Figure 3.5A). Together with the solution 
data, the ESI-MS data exclude the formation of a covalent disulfide bridge between 
the inhibitor sulfhydryl group and the side chain of Cys168 present in the active site 
of the BcII enzyme (21), since a covalent interaction would not be expected to be 
disrupted by the higher collision energy induced by increase of the cone voltages. 
 
Selection of the cone voltage for the study of BcII inhibitors by ESI-MS 
In order to compare the relative affinities of different thiol inhibitors for BcII by ESI-
MS, a single sample cone voltage has to be selected where the relative abundance 
of each Zn2-BcII-inhibitor complex compared to the Zn2-BcII is optimal. The relative 
abundance of Zn2-BcII-inhibitor complexes compared to Zn2-BcII at different cone 
voltages for (R,S)-thiomandelate, thiosalicylate and 4-mercaptobenzoate is illustrated 
in Figure 3.6. The abundance of the bound and unbound species were measured 
from the peak area of the two main charge states observed for the BcII enzyme (z = 
9, z = 10). The data for the + 8 charge state were not used, due to its insignificant 
intensity. 
The relative abundance of the Zn2-BcII-thiomandelate complex compared to the Zn2-
BcII complex was constant (70.7 ± 2.5 %) from cone voltages 20 to 50 V, but 
decreased as the cone voltage was increased to 90 V, where only 20 % of the 
complex relative to that at 20 V was detected. 
A similar behavior was revealed for the Zn2:BcII:thiosalicylate and the Zn2:BcII:4-
mercaptobenzoate complexes; the effect was more apparent for 4-mercaptobenzoate 
where at 50 V only 20 % of its complex with Zn2:BcII was observed and was 
undetectable at 90 V. Due to the effect of the cone voltage on the apparent relative 
stability of the Zn2-BcII-inhibitor complexes, measurements for the comparison in the 
binding of different inhibitors to Zn2-BcII were performed at a constant cone voltage 
of 50 V, thus enabling the observation of all complexes and therefore enabling their 
comparison. Use of lower cone voltages led to an inefficient desolvation resulting in a 
significantly lowered degree of mass accuracy. 
 
 
 
 
 
  CHAPTER III 
 
63
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6: Relative abundance of Zn2-BcII-inhibitor complexes compared to the inhibitor –
free Zn2-BcII complex (%) based on peak area integration at different sample cone voltages 
for (R,S)-thiomandelic acid (TM), thiosalicylic acid (TC) and 4-mercaptobenzoic acid (4-
MBA). All experiments were performed in ammonium acetate buffer (pH 7.5) with a pressure 
at the interface of 6.7 mbar. 
 
Determination of the relative affinities of thiol inhibitors on BcII using ESI-MS 
Figure 3.7 shows the ESI mass spectra obtained for Zn2-BcII after incubation with 1.3 
equivalents of (R,S)-thiomandelate (Figure 3.7A), thiosalicylate (Figure 3.7B), and 4-
mercaptobenzoate (Figure 3.7C). Analysis of the spectra for the three inhibitors 
revealed that ca. 70 % of Zn2-BcII is associated with (R,S)-thiomandelate, compared 
to ca. 43 % for thiosalicylate and 27 % for 4-mercaptobenzoate. Inhibition constants 
KI were previously determined in solution (43). In those experiments, KI values of 
0.34 µM, 29 µM and 346 µM were determined for (R,S)-thiomandelic acid, 
thiosalicylic acid and 4-mercaptobenzoate, respectively. The authors explained that 
the compound affinity increased when the thiol and carboxylate groups are in close 
spatial proximity (43) which was in good agreement with the results obtained by ESI-
MS. With 1.3 molar equivalents of inhibitor relative to metalloenzyme, two further 
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molecules of 4-mercaptobenzoate were observed to bind to the Zn2-BcII complex but 
at a stepwisely decreasing abundance relative to the first one, suggesting a non-
specific binding for this inhibitor. A relative abundance of 33 % was observed for the 
Zn2-BcII-benzylmercaptan complex (Figure 3.7D), which is ca. 50 % less abundant 
than for thiomandelate acid, demonstrating that the presence of an appropriately 
positioned carboxylate group results in increased complex stability. Results 
previously obtained by spectrophotometric experiments in solution (43) are also 
consistent with the results obtained by ESI-MS in this work. A KI of 9 µM was 
obtained for benzylmercaptan. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7: ESI mass spectra of Zn2-BcII (15 µM) after incubation with 1.3 molar equivalents 
of (R,S)-thiomandelic acid (MW = 168.0 Da) (A), thiosalicylic acid (MW = 154.0 Da) (B), 4-
mercaptobenzoic acid (MW = 154.0 Da) (C) and benzylmercaptan (MW = 124.0 Da) (D). 
Experiments were carried out in ammonium acetate (pH 7.5), sample cone voltage 50 V, 
pressure at interface 6.7 mbar. The ions carrying the charges + 9 and + 10 are representated 
in the mass spectra. Metalloenzyme and metalloenzyme-inhibitor-complex and represented 
by circle and cresent, respectively. 
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Replacing the thiol group of (R,S)-thiomandelate by a hydroxyl group, i.e. with 
mandelate (data not shown), resulted in a significant loss of affinity where less than 5 
% of the Zn2-BcII-inhibitor complex was formed even in the presence of 5.3 
equivalents of inhibitor. This demonstrates that the presence of the thiol group is 
crucial for retaining the affinity with Zn2-BcII, consistent with previously reported UV 
spectroscopy results (43). Thus the overall structure activity relationship (SAR) data 
obtained by mass spectrometry is consistent with SAR obtained previously in solution 
(122). 
 
Determination of the dissociation constant KD using ESI-MS 
In order to obtain quantitative dissociation constant KD data for a particular inhibitor, 
titration experiments, similar to the solution measurements, were carried out by mass 
spectrometry. The dissociation constant KD value for the Zn2-BcII-thiosalicylate 
complex was obtained by titrating the BcII metalloenzyme with different 
concentrations of the inhibitor. The calculation of the KD value was performed by 
integrating the peak areas of the free metalloenzyme [E] and the BcII-inhibitor 
complex [EI]. The resulting ratio [EI]/[E] was used for the calculation of the absolute 
concentration of both species. Figure 3.8 shows the linear correlation between 
[EI]/[E] versus [II]-[EI] from 5 to 35 µM of thiosalicylate. The slope of the curve 
corresponds to 1/ KD which was 35.3 ± 3.8 µM in this experiment. This value is in 
good agreement with the UV spectroscopy studies, where a value of 29 µM (SD ≤ 20 
%) was determined (43). 
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Figure 3.8 Graphic showing the correlation between [EI]/[E] versus [II]-[EI] obtained for the 
titration of BcII (15 µM) with thiosalicylic acid (10-35 µM). The KI value calculated from the 
slope of the linear regression curve (in black) is 35.3 ± 3.8 µM. 
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3.3.2 Screening of new inhibitors using a dynamic chemistry approach 
combined with “native” ESI-MS 
A dynamic combinatorial chemistry (DCC) approach combined with the above 
described “native”- ESI-MS technique was developed by B. M. Liénard in Oxford 
(Group of Prof. C. J. Schofield, Oxford, UK) to identify oligomers that can act as 
useful templates for MBL inhibitor discovery (123). The DCC method employs 
dithiols, derived from a selected lead inhibitor (compound A, Table 3.2), where one 
thiol group is designed to interact with the two active site zinc ions of BcII and the 
other as a tether to support the dynamic disulphide exchange with selected dynamic 
combinatorial library (DCL) members. With the use of “native”- ESI-MS and selected 
knockout experiments, two disulfides having the potential to improve the inhibition 
efficiency of the lead inhibitor were detected.  
Since the two disulfides could not be synthesized, stable carba-analogues were 
synthesised (compounds B-F; Table 3.2). Analysis of the relative abundance of each 
of the Zn2-BcII-carbaanalogue complexes compared to the Zn2-BcII complex by 
“native” ESI-MS revealed that all synthesised carba-analogues display a better 
affinity for BcII:Zn2 compared to the lead compound A, which is also in agreement 
with the inhibition constants (KI) obtained by kinetic measurements in solution (Table 
3.2).  
Calculated KI values indicated that the optimium linker chain length for mimicking the 
disulphide tether comprises two methylene groups as demonstrated by a KI value of 
6 µM for compound C, which is also ca. 30 times more potent than the lead 
compound A. The highest KI value corresponds to the analogue with the shortest 
linker chain i.e. only one methylene group (compound B, table 3.2). The small 
variation in KI values observed with longer linker chains (compounds D and F, Table 
3.2) may partly be due to the flexible nature of one of the BcII active site main loop, 
know for its participation in substrate recognition and catalysis by folding over the 
active site cavity (124). 
The analysis of the relative ESI-MS affinity of compounds B-F for Zn2:BcII revealed 
that compounds with linkers comprising 2-4 methylene groups (a.k.a. C, D, F) are 
more potent than the compound B with the shortest linker chain. Moreover, in the gas 
phase the order of affinity potency is D > F > C, whereas the solution data gave C > 
F > D. Whilst the KI values determined in solution are reasonably similar, it seems 
that small differences in inhibition potency are not differentiated by ESI-MS. Besides, 
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the relative abundance of the complex Zn2BcII-E was found to be 51 % smaller than 
the compound with only one –CH2 group. Compound E has the same linker length 
than compound D, but without the second carboxylate group. It could be concluded 
that the interaction between the second carboxylate group and BcII are stronger in 
the gas phase compared to what was observed in solution. 
 
3.4 Effect of inhibitors on the metal stoichiometry of MBLs determined by 
ESI-MS 
As shown above, native ESI-MS is a suitable method for the evaluation of 
metal:enzyme:inhibitor ratios and therefore was further used to study the influence of 
two well known inhibitors (a.k.a (R,S)-thiomandelate and D-captopril: Figure 3.9) on 
the metal stoichiometry of MBLs.  
 
 
        
 
 
 
   1      2 
 
Figure 3.9: Structures of (R,S)-thiomandelic acid (1) and D-captopril (2). 
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Table 3.2: Inhibition constants (KI) determined in solution of lead compound A for the DCC 
study and the synthesized carbaanalogue compounds (B-F) for BcII and relative abundances 
(sum of the peak intensities of ions carrying the charge + 9 and + 10) of the Zn2BcII-inhibitor 
complexes (EI %) compared to the inhibitor-free Zn2BcII monitored with ESI-MS. The final 
concentration of Zn2-BcII and of each compound was 15 µM and 45 µM, respectively in ESI-
MS. Experiments were carried out in ammonium acetate (pH 7.5), cone voltage 50 V, 
pressure at interface 6.6 mbar.  
A
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3.4.1 Binding of inhibitors to cadmium and zinc BcII enzyme 
The case of (R,S)-thiomandelate 
The binding of (R,S)-thiomandelate to Cd1-BcII was investigated using ESI-MS 
(Figure 3.10). The Cd1-BcII complex was first analysed without the presence of the 
inhibitor to assess the amount of any dinuclear species observable in the ESI mass 
spectra (Figure 3.10A). The addition of less than one molar equivalent of (R,S)-
thiomandelate to the Cd1-BcII complex led to the formation of five new peaks which 
correspond to the Cd2-BcII-thiomandelate, Cd-Zn-BcII-thiomandelate, Zn2-BcII-
thiomandelate, apoBcII-thiomandelate and Cd2-BcII complexes (Figure 3.10B). Thus, 
it seems that mainly dinuclear species have the ability to interact with (R,S)-
thiomandelic acid, which may suggest that the inhibitor increases the affinity for 
binding of a second metal ion. The presence of the zinc-protein species can be 
explained by the presence of a residual amount of zinc in the apoprotein preparation 
and the inhibitor stock solution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: ESI mass spectra of the Cd1-BcII complex in absence (A) and in presence of 
(R,S)-thiomandelate (B) in ammonium acetate pH 7.5. 8 µM of (R,S)-thiomandelate is added 
to 9.8 µM apoenzyme and 9.8 µM cadmium. Sample cone voltage 50 V, pressure at interface 
6.7 mbar. The ions carrying the charges +9 and + 10 are representated in the mass spectra. 
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The binding mode of (R,S)-thiomandelate to the zinc enzyme BcII at 
[Zn2+]/[apoprotein] ratios < 1 was then investigated. Figure 3.11 show that three 
protein species, namely apo-, Zn1- and Zn2-BcII are present and coexisting when less 
than one molar equivalent of zinc ion to the protein is present in solution and in 
absence of inhibitor (Figure 3.11A). The addition of less than one molar equivalent of 
(R,S)-thiomandelate to the zinc enzyme BcII at [Zn2+]/[apoprotein] ratios < 1, resulted 
in the formation of a new peak which corresponded to the Zn2-BcII-thiomandelate 
complex, suggesting that the inhitor binds preferentially to the dinuclear species of 
BcII (Figure 3.11B). Here the increase of the sample cone voltage to a value of 200 V 
shows that the Zn2-BcII-thiomandelate is a non-covalent complex, since it is 
disrupted at this cone voltage (Figure 3.11C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11: ESI mass spectra of the zinc enzyme BcII in absence (A) and in presence of 
(R,S)-thiomandelate (TM) in ammonium acetate pH 7.5 at a sample cone voltage of 50 V (B) 
and in presence of (R,S)-thiomandelate (TM) at sample cone voltage of 200 V (C). 8 µM of 
(R,S)-thiomandelate is added to 9.8 µM apoenzyme and 8.4 µM zinc. Pressure at interface 
6.7 mbar. The ions carrying the charges + 9 and + 10 are representated in the mass spectra. 
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D-Captopril versus (R,S)-thiomandelate 
Table 3.3 shows the influence of D-captopril and (R,S)-thiomandelate on the metal 
stoichiometry of the zinc and cadmium BcII-enzymes. Incubation of D-captopril with 
the Cd1-BcII complex resulted in the formation of a dinuclear protein species binding 
the inhibitor as already observed with (R,S)-thiomandelate, but with lower peak 
intensities. Thus, D-captopril also increases the affinity for the binding of a second 
cadmium ion in BcII. Incubation of D-captopril with the zinc-enzyme of BcII at 
[Zn2+]/[apoprotein] ratios < 1 led to the formation of a new peak which corresponded 
to the Zn2-BcII-captopril complex. 
 
Table 3.3: Relative peak intensities (sum of the intensities of ions carrying the charge + 9 
and + 10) of the different protein BcII species as observed in ESI-MS when the zinc and 
cadmium enzyme BcII are incubated with (R,S)-thiomandelate (TM) or D-captopril (C) in 
ammonium acetate pH 7.5. ESI-MS spectra of the zinc enzyme are obtained by adding 8 µM 
(R,S)-thiomandelate or 15 µM D-captopril to 9.8 µM apoenzyme and 8.4 µM zinc. For the 
cadmium-enzyme, 8 µM (R,S)-thiomandelate or 15 µM D-captopril is added to 9.8 µM 
apoenzyme and 9.8 µM cadmium. 
with TM with C with TM with C
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3.4.2 Binding mode of (R,S)-thiomandelate to the CphA MBL 
The binding mode of (R,S)-thiomandelate with the Zn1-CphA complex was 
investigated (Figure 3.12). The addition of more than two molar equivalents of 
inhibitor to native mono-zinc CphA resulted in the formation of a new peak in the 
mass spectrum which could be assigned to the Zn2-CphA-thiomandelate complex. 
The monozinc complex (Zn1-CphA-thiomandelate) was not observed by ESI-MS 
under these experimental conditions. This observation suggests that the inhibitor 
induces the binding of the second metal ion. Moreover, the apo-CphA enzyme was 
not detected. Potentially, the formation of the Zn2-CphA-thiomandelate complex is 
caused by the presence of Zn(II) is likely to originate from the inhibitor stock solution. 
Furthermore the results indicate that the inhibitor changes the charge state 
distribution of the protein ions in the ESI mass spectra, which is usually a reliable 
indication of the presence of conformational changes in the protein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12: ESI mass spectra of Zn1-CphA in presence (A) and in absence (B) of 2.6 molar 
equivalents of (R,S)-thiomandelate in ammonium acetate pH 7.5. The final concentration of 
Zn1-CphA and (R,S)-thiomandelate was 15 µM and 38 µM, respectively. Sample cone 
voltage 50 V, pressure at interface 6.7 mbar. The ions carrying the charges + 9, + 10 and 
+11 are represented in the mass spectra. Metalloenzyme and metalloenzyme-inhibitor-
complex are represented by circle and cresent, respectively. 
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3.5 Effect of inhibitors on the metal ion binding mode of MBLs using UV 
spectroscopy 
In addition to ESI-MS, competition experiments with the chromophoric chelator Mag-
fura-2 were performed to determine the dissociation constants for zinc and cadmium 
ions to the metal-free enzymes BcII, CphA and L1 in presence and in absence of 
(R,S)-thiomandelate and D-captopril. Figure 3.13 represents the experimental data 
(absorbance change at 363 nm) and fitting of the Zn(II) and Cd(II) binding to the 
three enzymes in presence and in absence of the inhibitors. One-step and two- step 
binding models (as described in paragraph 2.2.3) were fitted to the data in absence 
and in presence of apoenzymes, respectively. The resulting dissociation constants 
are summarized in Table 3.4.  
The experimental data revealed that the zinc binding to the three enzymes is not 
drastically changed in presence of (R, S)-thiomandelate and D-captopril, whereas the 
cadmium binding is strongly affected. In fact, a higher concentration of Cd(II) ions is 
required for saturating the metal chelator with the inhibitors than without them. 
 
Table 3.4 summarises the apparent dissociation constants for the three zinc and 
cadmium MBLs in presence or absence of the inhibitors.  
The affinity for the binding of a second zinc ion increased slightly in presence of 
(R,S)-thiomandelate for all three zinc enzymes and is sufficient to induce positive 
cooperativity (KD2 < KD1) in zinc binding for BcII. In contrast, the addition of (R,S)-
thiomandelate to the three substituted cadmium-enzymes, led to the significant 
increase of the affinity for a second cadmium ion.  
D-captopril had a smaller effect on the zinc enzymes compared to (R,S)-
thiomandelate. The affinity recorded for the binding of a second zinc ion increased 
slightly for BcII and L1, whereas it became weaker for CphA. In contrast, D-captopril 
had a stronger effect on the Cd-enzyme L1. In the case of BcII and CphA, the 
dissociation constant for a second cadmium ion are slightly lower in presence of D-
captopril. 
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Figure 3.13: Determination of the affinity of the enzymes BcII, CphA, and L1 for Zn(II) and 
for Cd(II) in presence and in absence of (R, S)-thiomandelate and D-captopril by competition 
with Mag-fura-2 in 15 mM HEPES, pH 7 at 22 °C. The total absorbance change at 363 nm 
corresponding to the sum of metal-free Mag-fura-2 (MF) and metal-loaded Mag-fura-2 (Me-
MF) is a function of the added volume of 255 µM Zn(II) ion stock solution (left) and 255 µM 
Cd(II) ion stock solution (right) to a defined starting volume (1ml) in absence of apoenzymes 
( in grey), where a one-step binding model was fitted to the data (grey line) (A, B); in 
presence of apoenzymes ( in black), where a two-step binding model was fitted to the data 
(black lines) (A, B for BcII), (C, D for CphA) and (E, F for L1). The total absorbance change 
at 363 nm in presence of the inhibitors is represented as (□) for (R, S)-thiomandelate (6 µM) 
and (∆) for D-captopril (100 µM). 
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Table 3.4: Apparent dissociation constants of Me1 and Me2 species of the three MBLs 
namely BcII, CphA and L1 in presence and in absence of (R,S)-thiomandelic acid (TM) and 
D-captopril (C). Data for Zn(II) and Cd(II) binding were obtained from competition titrations 
with Mag-fura-2 as described in Paragraph 2.2.3. KD1 and KD2 represent the dissociation 
constants of the Me-MBL and the Me2-MBL complexes, respectively. 
 
 
  BcII CphA L1 
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KD2 
[nM] 
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3.6 DISCUSSION 
3.6.1 Validity of the ESI-MS method for the study of MBLs 
Relevance of the instrument parameters for the characterization of metallo-ß-
lactamases 
The observation of biological complexes preserved in solution by a number of weak 
interactions can be achieved using “native” ESI-MS and has been demonstrated in 
the past as well as in the present work. The stoichiometry of complexes, the mode of 
binding and the binding strength of potential ligands can be assessed by this 
technique. This has only been proven viable if the network of interactions stabilizing 
the native complex is retained in the gas phase. Indeed, inappropriate experimental 
settings of the ESI interface can translate into artefacts in the MS spectra, which may 
lead to misinterpretations of the data.  
An efficient ion desolvation usually requires the use of a counterflow of nitrogen gas, 
heat and collision induced dissociation (CID) in the atmosphere/vacuum interface. 
Variation of these parameters is known to affect the stability of complexes in the gas 
phase (84, 125, 126). In the present work, the influence of the accelerating voltage 
(VC) at the atmospheric/vacuum interface on the metal-enzyme BcII complex and the 
ternary metal-enzyme BcII-inhibitor complexes was evaluated.  
Whilst studying the zinc-enzyme BcII interactions, three protein species were 
observed in the ESI mass spectra during the zinc titration of apoBcII i.e. the apo, Zn1- 
and Zn2-BcII species. Increasing the accelerating voltage to 200 V did not alter the 
relative abundance of the three protein species indicating that none of the three BcII 
species are advantaged or discriminated during their transfer through the 
vacuum/atmospheric interface. 
In contrast, the accelerating voltage was shown to have a significant disrupting 
impact on the stability of the ternary metal-enzymes-inhibitor complexes. Progressive 
disruption of the non-covalent interactions between the inhibitor and the 
metalloenzyme were observed with increasing accelerating voltage value. Therefore, 
for comparing the binding strength of different inhibitors, this voltage value was kept 
constant throughout the study. The value of the appropriate accelerating voltage was 
determined by comparing the peak intensity corresponding to the different 
metalloprotein-inhibitor complexes at different accelerating voltages between 20 and 
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100 V. Below 30 V, low peak resolution due to inefficient ion desolvation was 
observed whereas at 90 V the peaks corresponding to a number of metalloprotein-
inhibitor complexes disappeared. Thus, a compromise should be achieved between 
efficient desolvation and non-destructive gas-phase collisions in order to detect these 
types of complexes. 
 
Specificity of the non-covalent complex: Observation of artefacts 
A number of reports about the presence of non-specific interactions in “native” ESI 
mass spectra are available (127, 128). Smith and Light Wahl suggested that non-
specific associations are rather formed in solution than in the gas phase. Aggregation 
leading to non-specific assembly through ion-ion or ion-molecule interactions in the 
gas phase is unlikely (128). During the ionization process, the ion concentrations and 
their presence in the gas phase remains relatively low; consequently, the probability 
that a charged molecule collides with a neutral molecule is very small (129). 
Furthermore, the aggregation of molecules with same polarity is not expected due to 
the coulombic repulsions (130). However, the hypothesis that non-specific 
aggregates are formed in the gas phase is not completely excluded. In fact, during 
the ionization process, the evaporation of the solvent leads to an increasing 
concentration of analytes in the small offspring droplets at the end of the Taylor cone. 
When the non-specific interactions survive the ionization process, they can be 
detected in the ESI mass spectra (128, 131). 
  To verify that the non-covalent interactions obtained in the ESI mass spectra 
are specific, a number of control experiments are required. This can be achieved by 
modifying the chemical equilibrium of the non-covalent complexes in solution. 
Variation of the experimental conditions (eg. pH, solvent, binding partners) can 
induce the formation of new signals in the ESI mass spectrum, demonstrating the 
specificity of the non-covalent complex obtained in the gas phase. In the case of the 
metal-protein interaction study, dissolving the metalloprotein in an organic solvent 
resulted in the observation of new peaks in the lower mass range corresponding to 
the metal-free species of BcII. Additionally, if the binding partner of the apoBcII is 
changed in solution as shown by replacing Zn(II) for Cd(II) ions, formation of new 
complexes such as Cd-bound species are observed in the ESI mass spectra. 
Furthermore, the saturation of apoBcII with Zn(II) ions resulted in the formation of the 
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expected metal : apoBcII binding stoichiometry only (i.e. 2:1). Any other metal-
substituted protein complexes such as Zn3-, Zn4- or Zn5-BcII were not observed.  
Control experiments were also carried out with the metalloprotein-inhibitor 
complexes. The addition of more than one molar equivalent of inhibitor to Zn2-BcII led 
to the formation of a Zn2BcII-inhibitor complex with a 1: 1 binding stoichiometry 
(except for 4-mercaptobenzoic acid, where a 1:3 binding stoichiometry was 
observed). Furthermore the addition of inhibitor to metal-free BcII did not produce any 
apoBcII-inhibitor complex (data not shown), which indicates that the inhibitor binds 
specifically to the active site metal ions. 
 
Quantification of the different protein species from the ESI mass spectra 
To determine the relative or absolute binding strength between an enzyme and a 
small molecule ligand using ESI-MS, the relative abundance of the different protein 
species observed in the mass spectra has to reflect that existent in solution. The 
distribution of the protein species in solution can be distorted during ion formation, 
ion desolvation and/or during transmission into the analyzer.  
In fact, peptides and proteins are ionized in solution by protonation of the basic 
residues or by deprotonation of the acidic residues. The charge state depends on the 
relative values between the pI of the protein and the pH of the buffer in solution. 
Enzymes bearing a global positive net charge are more likely to yield intense signals 
when the measurement is performed in the positive ion mode (132). 
During the ion desolvation, ionic interactions, hydrogen bonds and Van der Waals 
forces generally survive the ionization process but also the ionic bonds in particular 
are strengthened in the gas phase compared to the situation in solution (133). In 
contrast, hydrophobic interactions originating from the repulsion with water 
molecules, are not present in solvent-free environment. When hydrophobic 
interactions are the main forces involved in the cohesion of an enzyme-ligand 
complex, frequently no correlation is found between the binding strength in solution 
and the one observed in the gas-phase (134). In our metalloprotein-inhibitor studies, 
varying the distance between the thiol and the carboxylate groups of the 
mercaptocarboxylate compound has shown to significantly affect the binding affinity 
between the inhibitor and the enzyme as it was previously observed in solution (43). 
In the DCC-MS approach, ESI-MS data agreed reasonably well with the solution 
data, showing that a minimum of two methylene groups are required for efficient 
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inhibition of BcII. Therefore, it can be concluded that the major set of interactions 
between the metalloprotein BcII and the tested inhibitors are electrostatic forces. This 
is consistent with findings from crystal structures of MBLs with thiol-containing 
inhibitors, where both an interaction of the thiol group of the compounds with the 
metal ions in the active site of the protein (38) and an interaction of the carboxylate 
group with the side chain of a lysine residue (38) of BcII could be observed. 
One significant anomaly between the solution phase and the gas phase data sets 
was observed in case of benzylmercaptan, where the relative abundance of the peak 
corresponding to the Zn2-BcII-benzylmercaptan complex was lower compared to that 
of the Zn2-BcII-thiosalicylate complex. This is in contrast to UV-spectroscopy data in 
solution, which indicated for a higher affinity of BcII for benzylmercaptan (9 µM) than 
for thiosalicylate (29 µM). The obvious chemical structure differences between the 
two inhibitors are the presence of a carboxylate group in thiosalicylate and the 
aromatic thiol versus the benzylic thiol function. Similar contradictory results between 
gas-phase data and solution data were also found when the DCC-MS approach was 
applied; here, the relative abundance of the BcII-compound E complex was lower 
than that of the BcII-compound B complex, whereas in solution the KI values 
indicated that compound E (17 µM) is approximately six times more potent than 
compound B (102 µM). In this particular case, the chemical structure differences 
were the number of methylene groups constituting the proposed mimic arrangement 
for the disulfide bond and the presence of an additional carboxylate group on the 
second aromatic ring. One likely explanation for these discrepancies is that the 
interactions between BcII and benzylmercaptan or compound E are mainly 
hydrophobic whereas those involved between BcII and thiosalicylate or compound B 
have a more polar character. 
 
3.6.2 Metal binding to MBLs 
Despite having identical metal binding residues, namely 3-His for site 1 and DCH for 
site 2, the enzymes belonging to the B1 MBL subclass are known to have 
substantially different metal binding affinities. Indeed, the CCrA, Imp-1 and BlaB 
MBLs are known to bind tightly two Zn(II) ions (4, 135, 136), whereas very different 
affinities have been determined for the first zinc ion (KD1 = 1.8 nM) and the second 
zinc ion (KD2 = 1.8 µM), respectively, in case of BcII (4). Negative cooperativity in zinc 
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binding was therefore concluded for this enzyme. Even when using cadmium or 
cobalt in place of zinc ions in BcII, the dissociation constant for the binding of a 
second metal ion was found to be significantly higher compared to the binding of a 
first metal ion (KDCo1 = 93 nM; KDCo2 = 66.7 µM (39) and KDCd1 = 12.5 nM and KDCd2 = 
256 nM (11)).  
The present BcII metal binding study performing “native” ESI-MS revealed that two 
Zn(II) ions or two Co(II) ions bind tightly to BcII. Mag-fura-2 experiments revealed 
dissociation constants values for the binding of one and two zinc ions, which were 
found to be lower than 1 nM. The determined value KD2 was revised by a factor of 
2000 compared to that previously reported (4). This difference in metal affinities with 
BcII is surprising and could not be explained up to now. The BcII enzyme used in this 
work was isolated from E. coli BL21(DE3). For cultivation, the cells were grown in 
minimal medium, whereas in all previous studies LB medium was used. LB-produced 
BcII samples showed a pink colouration (137), which was not observed in BcII 
samples isolated from cultivations on minimal medium. One reasonable explanation 
for the presence of this pink colouration could be the presence of a pigment in the 
case of the LB-produced BcII, which potentially posseses strong affinity for zinc (or 
cobalt) ions modifying the apparent metal:protein stoichiometry. Another possible 
reason for the difference in metal affinities is the presence of a small amount of N- 
terminally truncated BcII species, which has been observed by mass spectrometry in 
the LB-produced-BcII samples (data not shown). However, the BcII enzyme used in 
the present study was shown to be free of N- terminally truncated BcII species. 
Furthermore, the analysis of the “non-denaturing” ESI mass spectra suggests that 
binding of the second Zn(II) ion to the apoenzyme BcII is positive cooperative. This 
conclusion is based on the observation that the ratio of KD1/KD2 » 1 and that the Zn1-
BcII complex was not observed as the predominant protein species during the 
titration of apoBcII monitored by ESI-MS. In constrast, both KD values obtained with 
the Mag-Fura titrations were not conclusive to determine the potential positive 
cooperativity in zinc binding to BcII. In fact, KD2 was found to be higher than KD1.  
In the ESI-MS experiments, it was assumed that the three protein forms i.e. apo, Zn1 
and Zn2-BcII displayed the same ionization efficiencies, though it could not be proved 
experimentally, due to the presence of the three protein species at low ratios of 
[Zn2+]/[apoprotein]. Therefore, these ESI-MS data have to be interpreted with care. In 
fact, a small difference in ionization effiencies of the BcII protein species will have a 
 DISCUSSION: METAL BINDING STUDIES 
 
81
significant impact on the pre-existent equilibrium in solution.  
Another parameter which has to be discussed is the determination of the 
concentration of the analytes in the gas phase. In fact, extensive evaporation of the 
charged droplets formed at the ESI spray tip increases the concentration of the 
analytes. A higher concentration of reactants in a droplet will shift the equilibrium of 
the reaction in solution: P + L = PL towards more PL product. Therefore it has also to 
be proved that the kinetic rate of the equilibrium shift is slower that the evaporation 
rate (121). 
When replacing zinc by cadmium ions, a sequential binding of the metal ion to BcII 
was observed by ESI-MS as well as in competition-titration experiments. These 
results were also consistent with the previously reported data using the BcII enzyme 
(4). Previous studies highlighted that the two binding sites require the same metal 
binding affinity, which led to the conclusion that the higher dissociation constant for a 
second metal ion could only be explained by negative cooperativity (39). Slow 
association rates for the formation of the Cd2-BcII enzyme determined by stopped-
flow fluorescence measurements suggested that a fast metal exchange between the 
two sites of the mononuclear enzyme was inhibiting the binding of a second metal ion 
(39). A parallel investigation on the dynamics of cadmium binding to the mononuclear 
BcII enzyme used a combination of PAC and NMR spectroscopic experiments (11). 
The results revealed that the metal quickly jumped between the two metal binding 
sites in a µs time regime and thus inhibited the binding of a second cadmium ion, 
which is responsible for negative cooperativity. In the past, metal ion interchange was 
also suggested for zinc binding to BcII (39). In the present study, using purified BcII 
enzyme from cultivation on miniminal medium, negative cooperativity for the zinc 
binding was not observed. It was therefore concluded that other parameters may be 
involved and that “zinc jumping” remains to be proven. 
 
3.6.3 Inhibition of native and cadmium-substituted MBLs 
1) D-Captopril 
Captopril, a well-known angiotensin converting enzyme-blocking agent (140), was 
previously shown to inhibit metallo-ß-lactamases (10). Kinetic studies have revealed 
that enzymes from the three MBL subclasses, loaded either partially or fully with 
metals, are inhibited by two of the captopril isomers. Furthermore, a combination of 
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several techniques including EXAFS, PAC and competition-titration experiments 
have shown that the mononuclear forms of BcII and CphA were preferentially 
inhibited by the inhibitor (10). The study demonstrated two different inhibitor binding 
modes: for the Cd1-BcII enzyme, the thiolate group of D-captopril binds to the single 
metal ion when located at the 3H site and its carboxylate group potentially interacts 
with the metal when it is located in the DCH site. Moreover, for the Cd1-CphA 
enzyme, only one binding mode was found i.e. the thiolate function of D-captopril 
coordinates the metal ion when it is located in the DCH site. CphA was also found to 
preferentially interact with the D- isomer of captopril.  
In the present study, the binding of D-captopril to the native zinc BcII and CphA 
enzymes was investigated using titration experiments with the chelating agent Mag-
fura-2 and “native”-ESI-MS. Additionally, the preference of D-captopril for the Cd1-
species of the BcII and CphA enzymes was verified. Besides, the inhibition of the 
enzyme L1, representative of subclass B3, was also investigated using Mag-Fura 
titrations.  
Similar dissociation constants for the binding of the first (KD1 = 0.9 nM) and second 
zinc ion (KD2 = 4.8 nM) were found for the L1 enzyme, consistent with previously 
published reports (4). The L1 enzyme is considered as a di-zinc enzyme. The binding 
of D-captopril to the L1 enzyme had no influence on KD values. L1 remained a Zn2-
form in presence of D-captopril. In the past, the crystal structure of the complex 
between another di-zinc enzyme of subclass B3, namely Fez-1 enzyme from 
Legionella gormanii, and D-captopril has been solved. The data revealed that the 
inihibitor is located close to the active site, but did not coordinate the two available 
zinc ions (45).  
For the cadmium-bound L1 enzyme, two different dissociation constants were found, 
i.e. 4.8 nM for the first Cd(II) ion and 40 nM for the second Cd(II) ion. In presence of 
D-captopril, the second dissociation constant decreased by 40 fold approaching the 
dissociation constant of the first one. This indicates that the mode of inhibition of D-
captopril may involve binding to the Cd2-L1 to achieve efficient inhibition. 
On the other hand, Mag-Fura titrations showed that D-captopril did not change the 
metal binding stoichiometry of the Cpha monozinc-enzyme. The strength of the 
interaction between D-captopril and Zn1-CphA is likely to be rather weak. In fact, the 
zinc-CphA-D-captopril complex could not be observed in the ESI experiments. In the 
CphA monocadmium-enzyme, D-captopril slightly decreased the dissociation 
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constant for the second metal ion from 400 nM to 110 nM. The compound may bind 
to the Cd1-CphA for efficient inhibition, which is consistent with previously reported 
EXAFS and PAC data (10). 
In the zinc BcII enzyme, the two zinc ions bind very strong to the active site. In the 
presence of D-captopril, the dissociation constant for a second zinc ion was not 
significantly lower compared to the un-inhibited enzyme. D-captopril required two zinc 
ions for efficient binding to BcII, as clearly shown by the results of the ESI 
experiments. Despite the fact that the apo, Zn1 and Zn2-BcII species were present at 
low zinc concentrations, only the Zn2-form was found to bind the inhibitor. In the 
crystal structure of the D-captopril complex with another MBL of subclass B1, namely 
BlaB enzyme from Chryseobacterium menigoseptcum, it was found that the inhibitor 
interacts with the two active site zinc ions (44). BlaB is also considered a di-zinc 
enzyme. 
Furthermore Mag-Fura titrations revealed that D-captopril did not significantly 
change the dissociation constant for a second cadmium ion in the BcII-enzyme i.e. 
210 nM without inhibitor and 170 nM with inhibitor. Previous EXAFS and PAC data 
showed that the monuclear form of BcII is the preferred target for inhibition (10). In 
contrast, the present ESI-MS analysis revealed only the presence of the dinuclear 
BcII species with bound D-captopril. One possible explanation is that the inhibitor 
exhibits two binding modes i.e. inhibition of the native Cd1-form and to a certain 
extent induction of dinuclear-forms and that only the latter one survives the transfer 
from solution into the gas phase. 
In conclusion, depending on the subclass of metallo-ß-lactamase and the nature of 
the metal ion, D-captopril adopts different binding modes to convey its inhibitory 
effect, i.e. D-captopril seems to be able to interact with both mono- and di-zinc MBL. 
Whatever the nature of the metal ion is, D-captopril seems to interact with M2-L1 only 
and Me1-CphA only, whereas in the case of BcII, the metal stoichiometry, upon 
binding of D-captopril, depends on the nature of the metal ions itself, i.e. two metals 
when incubated with zinc and one or two metals with cadmium. 
 
2) (R,S)-Thiomandelate 
The inhibition by both enantiomers of thiomandelate has been previously assessed 
on different MBLs loaded with two zinc ions (43). (R,S)-thiomandelate was shown to 
be a potent inhibitor of subclasses B1 and B3 MBLs. Inhibition constants for the 
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dizinc BcII were 90 nM and 1280 nM for the R- and S-thiomandelate, respectively. 
Structure activity relationship (SAR) data in solution (43) and in ESI-MS (122) clearly 
showed that the thiol group is essential for inhibition and that the presence of the 
carboxylate group increases the inhibitory potency. A NMR/PAC study has also been 
performed with the Cd2-BcII (9), showing that both enantiomers interact with the two 
cadmium ions via the thiol group and that the carboxylate group may interact with 
Arg91. This was observed previously for the complex between a 
mercaptocarboxylate ligand and the enzyme IMP-1 (38). In presence of one cadmium 
ion in the active site of BcII, the compound was shown to induce positive 
cooperativity in metal binding by PAC/NMR experiments (9). 
In the present study, the interaction between zinc and cadmium-bound BcII, CphA 
and L1 enzymes and (R,S)-thiomandelate was investigated using competition titration 
experiments in solution. Native ESI-MS was only used for the study of BcII and 
CphA.  
The titration-experiments revealed that the binding of (R,S)-thiomandelate to the zinc-
L1 enzyme significantly decreased KD2 and slightly increased KD1. (R,S)-
Thiomandelate required the two zinc ions for efficient inhibition in the di-zinc-L1 
enzyme. In the cadmium-bound L1 enzyme, (R,S)-thiomandelate had the same effect 
as D-captopril, i.e. it leads to a 40-fold decrease of KD2. (R,S)-thiomandelate might 
also require two cadmium ions for efficient binding in the L1 enzyme.  
The binding study carried out with (R,S)-thiomandelate and zinc-CphA monitored by 
ESI-MS indicated that the inhibitor induced the production of dinuclear zinc-species. 
The presence of the two zinc ions seems to be required for efficient binding of (R,S)-
thiomandelate. However the Mag-Fura titrations revealed only a minor variation of the 
KD2 value in the zinc-CphA enzyme. This may be explained by the low amount of 
(R,S)-thiomandelate (6 µM) added during the titrations experiments, which might not 
have been enough to inhibit the total amount of CphA enzyme present. In fact, the 
inhibition constant of (R,S)-thiomandelate for CphA has been found to be 144 µM 
(43).  
In cadmium-substituted CphA enzyme, (R,S)-thiomandelate decreased dramatically 
the dissociation constant for the binding of a second cadmium ion by 200-fold. Thus, 
this inhibitor produced the dinuclear form of CphA. 
The inhibitory effect of (R,S)-thiomandelate on the cadmium-bound BcII enzyme 
decreased the KD2 value from 210 nM to less than 0.1 nM. The inhibitor required two 
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cadmium ions for binding to BcII. This was consistent with the ESI-MS results, where 
(R,S)-thiomandelate showed to induce only the formation of inhibited dinuclear 
protein species in the Cd1-BcII enzyme. Moreover, the apparent KD values 
determined in solution did not indicate any positive cooperativity of cadmium binding 
when incubated with the compound, which is not consistent with previous reports (9).  
On the other hand, positive cooperativity of zinc binding (KD2 < KD1) was induced by 
(R,S)-thiomandelate when incubated with the zinc enzyme BcII, as determined by 
titration experiments in solution. Further on, the ESI-MS results show that (R,S)-
thiomandelate only inhibited the dinulear form of BcII at a metal: protein stoichiometry 
below 1.  
In conclusion, it was found that the MBL inhibitor (R,S)-thiomandelate binds to BcII, 
CphA and L1 enzymes with a strong preference for binding to the dizinc species. This 
metal form may be induced upon inhibitor binding like it is the case for Zn- and Cd- 
CphA, Cd-L1 and Cd-BcII enzymes or native Zn-L1 and Zn-BcII enzymes. 
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4 METAL AND INHIBITOR DEPENDENT PROTEIN FLEXIBILITY: RESULTS 
4.1 Circular Dichroism (CD) spectroscopy 
CD spectroscopy was used to measure the difference in secondary structure 
between the different metal-loaded species of BcII. The CD spectra of the apo, Zn1, 
Zn2, Cd1 and Cd2-BcII species are shown in Figure 4.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Circular dichroism spectra of BcII species. Experimental data are represented by 
symbols, smoothed spectra by lines. (A) Spectra of apo-BcII (open circles), Zn1-BcII (open 
squares), and Zn2BcII (open triangles); (B) Difference spectra of Zn1-BcII – apo-BcII (open 
squares), Zn2-BcII – apoBcII (open triangles), and Zn2-BcII – Zn1-BcII (filled circles); (C) 
Spectra of apo-BcII (open circles), Cd1-BcII (open squares), and Cd2-BcII (open triangles); 
(D) Difference spectra of Cd1-BcII – apo-BcII  (open squares), Cd1-BcII – apo-BcII (open 
triangles), and Cd2-BcII – Cd1-BcII (filled circles). 
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A significant change in the 230-210 nm range of the spectrum was monitored when 
metals were added to the apoenzyme. Binding of two metals ions increased the 
intensities of the negative band at 220 nm compared to the metal-free enzyme, 
indicating an increase in secondary structure content. The addition of one zinc ion 
showed the same band intensity at 220 nm as for the Me2-BcII species, an additional 
shoulder at 210 nm was observed. Thus, the binding of one Zn(II) ion had a more 
pronounced effect on the secondary structure than the addition of a second Zn(II) 
ion. The addition of one cadmium ion yielded a band intensity at 220 nm, which was 
between the apoenzyme and the Me2-BcII proteins; the binding of only one Cd(II) 
might not be sufficient to reach the maximum of secundary structure elements. 
 
4.2 Hydrogen/Deuterium Exchange-Mass Spectrometry 
To follow and localize structural changes inside the BcII protein, HDX-MS combined 
with protein fragmentation was performed using the method described in paragraph 
2.2.10: In the first step, the peptides generated by digestion of BcII with pepsin were 
identified and assigned to the protein. In a second step, the H/D exchange of the 
peptic-peptides was monitored in apo, Zn1, Zn2, Cd1 and Cd2-BcII species using 
MALDI-ToF/ToF/MS. 
 
4.2.1 Assignment of the peptic-peptides to BcII protein 
The identification of the peptic-peptides of BcII and their selection for the HDX 
experiments was performed after analysis of the peptide mass fingerprint (PMF) (see 
appendix 2). 
In the PMF, 33 peptides in the mass range of m/z 800-3500 could be assigned to the 
BcII protein. A sequence coverage of 98 % was reached and all metal ligands could 
be identified. The average mass accuracy of identified peptides was 3.5 ppm. The 
amino acid sequence of all peptides was validated by tandem mass spectrometry 
using post source decay (PSD) with post-acceleration technique (see MS/MS 
spectrum in appendix 3 as an example). The same peptides could be assigned to the 
protein for all metal-substituted species namely Zn1, Zn2, Cd1 and Cd2-BcII species.  
Due to peak overlapping caused by the different number of exchangeable protons, 
the extent of deuteration could not be unambiguously analyzed for all 33 peptic-
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peptides after incubation of the protein in deuterated buffer; only 22 peptides 
covering almost 96 % of the protein sequence (Figure 4.2, Table 4.1) were 
accessible, again containing all residues belonging to the two metal binding sites 
were amongst the interpretable sequences. The three metal ion ligands of the C-
terminal domain, namely His149, Cys168, and His210 were found in the peptide 
fragments P[139-155], P[165-188], and P[205-219], respectively. The typical MBL 
superfamily sequence motif HxHxD was found in P[82-110] from the N-terminal 
domain.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2: Sequence coverage of the BcII enzyme reached in PMF analysis of a 10 
minutes-pepsin-digested apoenzyme BcII. Each bar corresponds to a peptic peptide, which 
was identified by tandem mass spectrometry and further on analysed by HDX-MS. 
Secondary structures are labelled by an arrow for the β-sheets and a spring for the α-helices. 
Metal ligands for the first binding site are His86, His88, His149 (His116, His118 and His196 
in the class B ß-lactamase (BBL) numbering (20)). Metal ligands of the second binding site 
are Asp90, Cys168, His210 (BBL: Asp120, Cys221, His263). 
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4.2.2 Determination of the deuterium uptake for one in-exchange time 
In order to follow the deuterium uptake of the 22 peptic peptides for the different 
metal-substituted species, the centroid mass of each isotope cluster of the 22 
deuterated peptides was calculated for each in-exchange time (Figure 4.3). 
Subsequently their masses were subtracted from the centroid mass of the non-
deuterated one and corrected as described in Paragraph 2.2.11. In the following 
study, the data are shown for selected peptides after an incubation time of 2000 sec. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: MALDI-mass spectra of selected peptic-peptides P[220-227], m/z = 952.581; 
P[82-110], m/z = 3106.751; P[55-66], m/z = 1422.675; P[22-31], m/z = 1239.650; P[189-205], 
m/z = 2064.100; P[139-155], m/z = 1933.965 in deuterated buffer after 2000 sec for apo-, 
Cd2-, Cd1-, Zn1-, Zn2-BcII species and after a 100 % deuteration (100 %D).  
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Table 4.1: Deuterium uptake within selected peptic-peptides after 2000 sec. In column 1 and 
2, the sequence of the analysed peptides and their corresponding experimental mass are 
given. In column 3, the number of peptide amide protons in the peptide is represented. In the 
columns 4-8, the number of deuteriums incorporated in the peptide for apo, Zn1, Zn2, Cd1 and 
Cd2-BcII species are shown. 
Sequence of 
identified peptides 
[MH]+ NH apo-
BcII 
Zn1-BcII Zn2-BcII Cd1-BcII Cd2-BcII 
N-term. tail (β1, β2) 
1SQKVEKTVIKNETGTISISQL21 
 
2303.280 
 
20 
 
17.7 ± 1.0 
 
15.1 ± 0.6 
 
15.1 ± 0.6 
 
16.6 ± 0.04 
 
15.6 ± 0.8 
β3, loop 32-39, β4, β5 
44LVLNTSKGLVL54 
22NKNVWVHTEL31 
32GSFNGEAVPSNGLV- 
LNTSKGLVL54 
 
1156.737 
1239.650 
2273.196 
 
11 
10 
22 
 
5.8 ± 0.2 
5.1 ± 0.1 
13.5 ± 0.6 
 
4.4 ± 0.6 
3.3 ± 0.1 
9.2 ± 1.6 
 
4.8 ± 0.4 
2.4 ± 0.2 
11.5 ± 0.8 
 
5.0 ± 0.2 
3.0 ± 0.2 
11.6 ± 0.5 
 
4.9 ± 0.4 
2.5 ± 0.2 
11.9 ± 0.9 
loop 56-60 
55VDSSWDDKLTKE66 
 
1422.675 
 
12 
 
8.5 ± 0.1 
 
5.9 ± 0.3 
 
3.7 ± 0.6 
 
7.1 ± 0.4 
 
5.5 ± 0.3 
αI, β6 
71VEKKFQKRVTD81 
70MVEKKFQKRVTD81 
 
1377.788 
1508.827 
 
11 
12 
 
7.1 ± 0.6 
7.3 ± 0.4 
 
5.9 ± 0.1 
6.2 ± 0.1 
 
6.1 ± 0.7 
6.3 ± 0.6 
 
6.5 ± 0.03 
6.4 ± 0.2 
 
5.7 ± 0.3 
5.8 ± 0.3 
αII, β7 
82VIITHAHADRIGGIKTLKER-
GIKAHSTAL110 
 
3106.751 
 
29 
 
27.3 ± 1.5 
 
18.3 ± 0.3 
 
14.4 ± 1.1 
 
21.3 ± 0.9 
 
17.3 ± 0.3 
Connecting Loop, β8 
130VTNLKFGNM138 
115AKKNGYEEPLGDLQT129 
114LAKKNGYEEPLGDLQTVTNL133 
 
1023.534 
1662.828 
2203.161 
 
9 
14 
19 
 
7.6 ± 0.2 
11.0 ± 0.7 
16.5 ± 0.7 
 
5.9 ± 0.9 
7.7 ± 0.7 
12.7 ± 1.1 
 
6.4 ± 0.7 
8.5 ± 0.9 
13.2 ± 0.5 
 
7.1 ± 0.4 
9.6 ± 0.5 
14.6 ± 0.7 
 
6.7 ± 0.3 
8.5 ± 0.8 
13.0 ± 0.5 
β9 
139KVETFYPGKGHTEDN153 
139KVETFYPGKGHTEDNIV155 
 
1721.815 
1933.965 
 
14 
16 
 
8.0 ± 1.0 
9.1 ± 0.7 
 
5.6 ± 0.2 
4.8 ± 0.04 
 
3.4 ± 0.4 
3.3 ± 0.5 
 
3.6 ± 0.7 
3.6 ± 0.1 
 
3.3 ± 0.3 
2.9 ± 0.2 
β10 
156VWLPQYNIL164 
 
1145.637 
 
8 
 
2.5 ± 0.1 
 
1.4 ± 0.3 
 
1.8 ± 0.02 
 
1.7 ± 0.1 
 
1.8 ± 0.1 
β11, Loop 174-185 
165VGGCLVKSTSAKD-
LGNVADAYVNE188 
 
2410.205 
 
24 
 
17.1 ± 1.1 
 
14.0 ± 0.2 
 
14.4 ± 1.1 
 
16.4 ± 0.3 
 
14.9 ± 0.6 
αIV 
195NVLKRYRNIN204 
189WSTSIENVLKRYRNIN204 
189WSTSIENVLKRYRNINA205 
 
1289.751 
1993.058 
2064.100 
 
10 
16 
17 
 
7.2 ± 0.8 
9.9 ± 0.7 
10.7 ± 1.1 
 
5.7 ± 0.1 
7.1 ± 0.2 
8.0 ± 0.2 
 
5.2 ± 0.4 
5.7 ± 0.4 
6.0 ± 0.3 
 
5.2 ± 0.1 
5.2 ± 0.04 
6.0 ±0.1 
 
4.7 ± 0.6 
5.1 ± 0.4 
 5.6 ± 0.7 
C-term. tail, β12, αV 
220LHTLDLLK227 
205AVVPGHGEVGDKGLL219 
205AVVPGHGEVGDKGLLL220 
205AVVPGHGEVGDKG-
LLLHTLDLLK227 
 
952.581 
1447.793 
1560.880 
2381.349 
 
8 
14 
15 
22 
 
5.5 ± 0.4 
10.5 ± 0.2 
10.9 ± 1.0 
17.3 ± 0.8 
 
3.1 ± 0.3 
6.8 ± 1.5 
8.0 ± 0.8 
13.2 ± 0.1 
 
1.6 ± 0.4 
8.3 ± 0.4 
9.1 ± 0.4 
11.8 ± 0.5 
 
1.1 ± 0.2   
8.0 ± 0.3 
8.5 ± 0.7 
11.7 ± 0.2 
 
2.8 ± 0.4 
7.7 ± 0.7 
8.4 ± 0.7 
12.7 ± 0.8 
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The average back exchange for 22 peptic-peptides was around 45 %, but individual 
values for each peptide were determined and used for data correction (see appendix 
4). Depending on the total number of exchanged amide protons in a peptide the 
resulting standard deviations were highly variable, ranging between 2 and 12 %. In 
Table 4.1 a comparison of H/D exchange of apo-BcII and the metal-substituted 
species after 2000 sec is listed. The total number of exchangeable amide protons 
and the experimentally observed exchange are compared. Some sequence sections 
are found in several peptides, which is caused by the occurrence of alternative 
cleavage sites of pepsin.  
 
4.2.3 Quantification and structural interpretation of the Hydrogen/Deuterium 
Exchange kinetics 
14 peptides mapped in Figure 4.4, covering almost 96 % of the protein sequence, 
were used to probe the influence of metal and inhibitor binding on HDX kinetics 
between 50 sec and 5900 sec. After analysis of the HDX kinetics, only a part of the 
totally possible HDX was time resolved. In fact, for most peptides, the H/D exchange 
has already begun in the dead time prior to the first measurement. The crystal 
structure of the Zn2-BcII enzyme is available from the protein data bank (PDB 
accession code: 1BVT), which allows for the determination of the solvent accessibility 
of the amide protons from the 14 peptides. 216 amide protons were covered in total 
by these peptides. 
Three types of amide protons were classified as follows: First, the amide protons 
involved in main chain - main chain (mc-mc) hydrogen bonds. They comprise 
spatially neighbouring peptide bonds found in α-helices, ß -sheets or turns (126 in 
total). They are protected against solvent and thus show generally slow HDX. The 
same might hold true for amide protons involved in hydrogen bonds to side chains 
(mc-sc) of spatially neighbouring amino acids (15 in total). Best solvent accessibility 
and highest rates of HDX are expected for amide protons not involved in hydrogen 
bonds.  
In Table 4.2, the total number of exchangeable amide protons is presented together 
with the numeric values for mc-mc and mc-sc hydrogen bonds determined from the 
crystal structure (1BVT). For the representation in Figure 4.4 these structural 
parameters are used to derive the %HDX expected when the amide protons not 
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involved in hydrogen bonds were exchanged. Generally, the percentage of non-
hydrogen-bonded amide protons correlated well with the first data points obtained of 
the HDX kinetics of Zn2BcII (Figure 4.4). Thus it might be concluded that at least all 
hydrogen-bonded amide protons are largely protected against HDX for incubation 
times < 50 s. The %D0 values resulting from data evaluation (Table 4.2) thus 
represented the non-hydrogen bonded amide protons. In fact, enzyme species 
showing considerably higher percental HDX at t = 50 s might have structures with a 
decreased number of hydrogen-bonded amide protons for the respective peptides. 
 
4.2.4 Hydrogen/Deuterium Exchange in the N-terminal domain of BcII 
Three peptides of the N-terminal domain revealed higher %D0 values for the apo and 
Me1-species than for the di-zinc form of BcII. These peptides are P[82-110], P[115-
129] and P[55-66].  
In the crystal structure of the di-zinc BcII (1BVT), P[82-110] spans the metal ion-
binding HxHxD motif and two secondary structure elements; the α-helix II and the ß-
sheet 7. In this peptide, 20 out of 29 amide protons are involved in 16 mc-mc and 4 
mc-sc interactions. Thus only 9 out of 29 amide protons (31 %) are accessible to the 
solvent, explaining the low %D0 value (i.e. 30 %) obtained from the HDX-MS data for 
the Zn2-BcII. In the case of the apoenzyme and Me1-BcII, %D0 values of 80 and 45 % 
were found for this peptide, respectively. This can only be explained by a decreased 
number of hydrogen-bonded amide protons. In the case of the apoenzyme, the 
secondary structure elements existing in this peptide should be partially unfolded. 
Similar effects of metal ion loading were observed for the peptide P[115-129]. 
In the crystal structure of the di-zinc BcII (1BVT), P[115-129] covers the loop 
connecting the N- and C-terminal domains. In this peptide, 11 out of 14 amide 
protons from P[115-129] are involved in 9 mc-mc and 2 mc-sc interactions. Thus only 
3 out of 14 amide protons (21 %) are accessible to the solvent, which is close to the 
%D0 value (i.e. 30 %) evaluated from the HDX-MS data for the Zn2-BcII. In the case 
of the apo-BcII and Me1-species, %D0 values of 63 % and 45 % were obtained, 
respectively. Here, the connecting loop is more flexible in the apo-and Me1-species 
than in the di-zinc BcII. 
In the crystal structure of di-zinc BcII (1BVT), the peptide P[55-66] contains the loop 
56-60. In this peptide, 9 of 12 amide protons are involved in 7 mc-mc and 2 mc-sc 
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interactions. Thus 3 out of 12 amide protons (20 %) are not protected against the 
solvent, which is consistent with the %D0 value of 18 % obtained from the HDX-MS 
data for the Zn2-BcII. Here also higher %D0 values were found with apo-BcII and the 
Me1-species. 
Although the %D0 values of the three peptides (P[82-110], P[115-129] and P[55-66]), 
were similar for the Me1-species, the Zn1-species showed shorter half life for the 
kinetically resolved reaction phase than the Cd1-species (Table 4.2). Furthermore, 
the number of non-exchanged amide protons (%Hend) was lower for the Cd1- than for 
the Zn1-species. In case of the Me2 species, the %Hend value was also lower for the 
Cd2-species, revealing more flexibility. 
The kinetic analysis of HDX resulted in the highest %D0 and/or %Dt values and short 
half life for most of the peptides in the N-terminal domain of apo-BcII compared to the 
other species (Table 4.2). Only one peptide was found to reflect similar exchange 
patterns in all protein forms, namely the peptide P[70-81] covering regions of the C-
terminus of α1 and the N-terminus of ß6 . 
Another peptide, P[32-54], showed longer half life in the Zn1-species (t1/2 = 37 min) 
than in the di-zinc form of BcII (t1/2 = 6 min). This peptide spans the loop 32-39 (a.k.a  
subtrate binding loop) and ß4. 
 
4.2.5 Hydrogen/Deuterium Exchange in the C-terminal domain of BcII 
Most of the peptides in the C-terminal domain revealed similar %D0 values for the 
different metal loading states, but indicated different numbers of non-exchanged 
amide protons at the end of the HDX process (%Hend). The metal-free BcII form was 
always the most solvent accessible form for these regions. Generally the resulting 
%Dt values were higher for apo-BcII. One exception was observed in case of the 
peptide P[165-188]: the %Dt value and the rate constant of the process of the H/D 
exchange were both higher in the Cd1-enzyme (%Dt = 24.8 and k = 1.52 min-1) than 
in the apoenzyme (%Dt = 14.6 and k = 0.02 min-1). This peptide covers the metal 
ligand Cys168 and the minor loop 174-185, which flanks the active site of the protein. 
Two peptides P[189-205] and P[220-227], covering the α-helices IV and V of the 
protein, respectively showed higher stability against HDX for the Cd1-form compared 
to Zn2-BcII (Figure 4.4). Similar results were found for P[139-155], which contains the 
147-152 loop and the metal ligand His149.  
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Four peptides of the C-terminal domain spanning the residues 156-219 showed more 
stability with one zinc ion than with two zinc ions. This is most pronounced for P[205-
219] containing the metal ligand His210 from the metal-binding site 2 (Figure 4.4). 
 
2D Graph 1
0
20
40
60
80
1 10 100
0
20
40
60
80
1 10 100 1 10 100
1 10 100
time [min]
1 10 100
1 10 100
0
20
40
60
80
de
u
te
ra
tio
n
 
[%
]
0
20
40
60
80
1 10 100
0
20
40
60
80
1 10 100
0
20
40
60
80
0
20
40
60
80
0
20
40
60
80
P[139-155]
P[189-205]
P[220-227]
P[165-188]
P[205-219] P[1-21]
P[22-31]
P[32-54]
P[70-81]
P[55-66]P[82-110]
1 10 100
P[115-129]
1 10 100
P[130-138]
P[156-164]
1-2
1
C-terminal 
domain
N-terminal 
domainconnecting loop
1-2
1
22
-
3132
-
54
55-66
70-8
1
82-110
115
-
129
13
0-
13
8
139
-155
15
6-
16
4
16
5-1
88
189-205
205
-
219220-227
Thr
-
7
Cys
-168
His
-210
Asp-90
His-88
His-86
His
-149
 
Figure 4.4: HDX kinetics of BcII. The time courses of percentage deuterium in-exchange are 
given on a logarithmic time scale. Experimental data for the different enzyme species are 
presented as follows: apo-BcII (black circles), Zn1-BcII (half-filled red circles), Zn2-BcII (filled 
red circles), Cd1-BcII (half-filled blue squares), Cd2-BcII (filled blue squares). The theoretical 
curves are represented by lines through the data points and were obtained from fitting 
equation 2.11 to the data. The percentage of amide hydrogens not involved in main chain - 
main chain (mc-mc) hydrogen bonds is indicated by full green lines, the percentage of amide 
hydrogens involved in neither main chain - main chain nor main chain - side chain hydrogen 
bonds is represented by broken green lines. The latter data were obtained from an inspection 
of the crystal structure of Zn2-BcII (1BVT).  
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Table 4.2: Results of the kinetic analysis of HDX data from Fig. 4.4. %D, %Dt (amplitude of 
the process), and k (rate constant) result from fitting Equation 2.11 to the data; %Hend = ΣNH 
- %D0 - %Dt; t1/2 = ln2/k. Percental deuterium in-exchange is given together with the standard 
deviation resulting from the fits. The corresponding number of protons (ΣHX) is given in 
brackets. 
 
peptide 
- ΣNH 
- mc-mc H-
bonds 
- mc-sc H-
bonds 
 
 
metal 
 
 
%D0 
(ΣHX) 
 
 
%Dt (ΣHX) 
 
 
%Hend (ΣH) 
 
 
k [min-1] 
 
t1/2 
[min] 
approx. 
 
P[1-21] 
20 
8 
0 
0 
1Zn 
2Zn 
1Cd 
2Cd 
74.0±1.2 (16) 
63.7±1.3 (13) 
59.0±2.3 (12) 
71.9±1.3 (15) 
65.2±1.4 (14) 
12.3±1.5 (3) 
15.0±2.1 (3) 
15.9±2.5 (3) 
13.9±2.3 (3) 
14.7±1.9 (3) 
13.7 (3) 
21.3 (4) 
25.1 (5) 
14.2 (3) 
20.1 (4) 
0.190±0.080 
0.072±0.028 
0.332±0.177 
0.055±0.023 
0.104±0.041 
4 
10 
2 
13 
7 
 
P[22-31] 
10 
9 
0 
0 
1Zn 
2Zn 
1Cd 
2Cd 
24.0±1.1 (2) 
18.6±1.8 (2) 
19.0±0.7 (2) 
22.2±0.8 (2) 
19.8±1.2 (2) 
38.3±2.5 (4) 
29.5±6.6 (3) 
23.0±1.5 (2) 
30.1±24.7 (3) 
13.7±6.7 (1) 
37.2 (4) 
51.9 (5) 
58.0 (6) 
47.7 (5) 
66.5 (7) 
0.035±0.006 
0.022±0.011 
0.0083±0.0081 
0.0071±0.0081 
0.016+0.016 
20 
32 
84 
98 
43 
 
P[32-54] 
22 
13 
1 
0 
1Zn 
2Zn 
1Cd 
2Cd 
43.5±1.9 (10) 
37.7±1.5 (9) 
37.9±1.5 (9) 
45.2±0.5 (10) 
41.4±1.2 (9) 
20.1±3.0 (5) 
13.9±6.6 (3) 
12.9±2.0 (3) 
11.5±1.0 (3) 
15.7±1.9 (4) 
36.4 (8) 
48.4 (11) 
49.2 (11) 
43.3 (10) 
42.9 (10) 
0.072±0.030 
0.019±0.019 
0.117±0.058 
0.040±0.009 
0.075±0.025 
9 
37 
6 
17 
9 
 
P[55-66] 
12 
7 
2 
0 
1Zn 
2Zn 
1Cd 
2Cd 
-5.4±1.4 (0) 
27.9±2.7 (3) 
18.0±0.6 (2) 
25.8±1.7 (3) 
22.9±2.3 (3) 
76.1±1.6 (9) 
21.0±3.0 (3) 
18.3±1.1 (2) 
35.3±2.5 (4) 
32.7±4.1 (4) 
23.9 (3) 
51.1 (6) 
63.7 (8) 
38.9 (5) 
44.4 (5) 
1.351±0.067 
0.243±0.126 
0.043±0.006 
0.082±0.017 
0.054±0.018 
0.5 
3 
16 
8 
13 
 
P[70-81] 
12 
8 
1 
0 
1Zn 
2Zn 
1Cd 
2Cd 
21.4±1.2 (3) 
14.5±1.6 (2) 
15.8±1.3 (2) 
19.9±1.2 (2) 
16.5±2.1 (2) 
50.7±2.3 (6) 
48.8±3.1 (6) 
51.0±2.5 (6) 
46.8±2.7 (6) 
46.7±4.3 (6) 
27.9 (3) 
36.7 (4) 
33.2 (4) 
33.3 (4) 
36.8 (4) 
0.041±0.005 
0.047±0.007 
0.045±0.006 
0.036±0.005 
0.039±0.009 
17 
15 
15 
19 
18 
 
P[82-110] 
29 
16 
4 
0 
1Zn 
2Zn 
1Cd 
2Cd 
78.8±2.1 (23) 
41.9±2.0 (12) 
27.5±2.4 (8) 
44.5±2.8 (13) 
29.5±1.2 (9) 
18.0±3.1 (5) 
22.4±2.7 (6) 
28.8±3.6 (8) 
36.7±4.6 (11) 
35.7±2.0 (10) 
3.2 (1) 
35.7 (10) 
43.7 (13) 
18.8 (5) 
35.5 (10) 
0.092±0.047 
0.114±0.044 
0.081±0.030 
0.065±0.022 
0.066±0.010 
7 
6 
9 
10 
10 
 
P[115-129] 
14 
9 
2 
0 
1Zn 
2Zn 
1Cd 
2Cd 
62.6±2.7 (9) 
44.2±4.0 (6) 
30.1±2.4 (4) 
48.6±1.3 (7) 
34.8±3.3 (5) 
13.7±3.0 (2) 
15.3±5.6 (2) 
32.1±3.0 (4) 
22.8±2.0 (3) 
29.8±4.4 (4) 
23.7 (3) 
40.5 (6) 
37.8 (5) 
28.6 (4) 
35.4 (5) 
0.786±0.386 
0.105±0.117 
0.139±0.044 
0.076±0.019 
0.126±0.060 
0.9 
7 
5 
9 
6 
 
P[130-138] 
9 
4 
0 
0 
1Zn 
2Zn 
1Cd 
2Cd 
37.0±1.9 (3) 
48.6±4.7 (4) 
47.6±2.0 (4) 
60.4±1.8 (5) 
53.7±1.6 (5) 
45.0±2.1 (4) 
19.2±5.3 (2) 
24.3±2.3 (2) 
19.6±2.9 (2) 
24.9±2.3 (2) 
18.0 (2) 
32.2 (3) 
28.1 (3) 
20.0 (2) 
21.4 (2) 
0.901±0.096 
0.245±0.245 
0.203±0.070 
0.069±0.028 
0.091±0.025 
0.8 
3 
3 
10 
8 
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P[139-155] 
16 
10 
3 
0 
1Zn 
2Zn 
1Cd 
2Cd 
21.7±1.4 (3) 
13.6±2.4 (2) 
11.6±0.6 (2) 
14.5±0.6 (2) 
13.4±1.2 (2) 
48.1±2.9 (8) 
27.6±4.7 (4) 
19.4±2.5 (3) 
19.6±5.6 (3) 
15.6±10 (2) 
30.2 (5) 
58.8 (9) 
69.0 (11) 
65.9 (11) 
71.0 (11) 
0.0368±0.0056 
0.0429±0.0184 
0.0202±0.0061 
0.0129±0.0068 
0.0130±0.0157 
19 
16 
34 
54 
53 
 
P[156-164] 
8 
7 
0 
0 
1Zn 
2Zn 
1Cd 
2Cd 
23.3±1.1 (2) 
13.3±1.1 (1) 
15.6±0.7 (1) 
18.1±0.3 (1) 
17.6±1.2 (1) 
32.2±4.7 (3) 
n.d. (<1) 
n.d. (<1) 
n.d. (<1) 
n.d. (<1) 
44.5 (4) 
76.5 (6) 
77.0 (6) 
79.0 (6) 
74.7 (6) 
0.0188±0.0061 
n.d. 
n.d. 
n.d. 
n.d. 
37 
n.d. 
n.d. 
n.d. 
n.d. 
 
P[165-188] 
24 
9 
1 
0 
1Zn 
2Zn 
1Cd 
2Cd 
61.9±1.2 (15) 
48.8±2.5 (12) 
55.4±0.8 (13) 
45.3±0.6 (11) 
18.9±1.5 (5) 
14.6±3.9 (4) 
11.1±2.8 (3) 
7.9±1.4   (2) 
24.8±0.6 (6) 
42.8±1.7 (10) 
23.5 (6) 
40.1 (10) 
37.6 (9) 
29.9 (7) 
39.2 (9) 
0.0235±0.0152 
0.6163±0.3824 
0.0698±0.0332 
1.5200±0.0966 
1.9540±0.2255 
30 
1 
10 
0.5 
0.4 
 
P[189-205] 
17 
11 
0 
0 
1Zn 
2Zn 
1Cd 
2Cd 
27.5±1.6 (5) 
24.0±2.0 (4) 
25.2±1.1 (4) 
28.2±1.6 (5) 
26.0±1.6 (4) 
50.4±3.8 (9) 
39.3±6.5 (7) 
25.2±5.2 (4) 
9.4±3.6   (2) 
13.7±3.4 (2) 
22.1 (4) 
36.7 (6) 
49.6 (8) 
62.4 (11) 
60.3 (10) 
0.0307±0.0058 
0.0230±0.0091 
0.0186±0.0085 
0.0338±0.0324 
0.0371±0.0230 
23 
30 
37 
21 
19 
 
P[205-219] 
14 
7 
1 
0 
1Zn 
2Zn 
1Cd 
2Cd 
44.7±1.8 (6) 
32.4±1.1 (5) 
37.6±1.3 (5) 
47.4±1.7 (7) 
41.3±1.9 (6) 
34.4±2.7 (5) 
18.5±1.8 (3) 
23.2±2.0 (3) 
14.8±3.5 (2) 
18.5±3.0 (3) 
20.9 (3) 
49.1 (7) 
39.2 (5) 
37.8 (5) 
40.2 (6) 
0.0808±0.0181 
0.0641±0.0171 
0.0851±0.0210 
0.0406±0.0241 
0.0751±0.0339 
9 
11 
8 
17 
9 
 
P[220-227] 
8 
8 
0 
0 
1Zn 
2Zn 
1Cd 
2Cd 
4.8±2.2 (0) 
4.5±1.8 (0) 
4.2±1.0 (0) 
4.5±1.2 (0) 
7.8±1.3 (1) 
83.9±4.6 (7) 
63.6±9.3 (5) 
64.2±20.8 (5) 
100±200 (8) 
74.5±10.9 (6) 
11.3 (1) 
31.9 (3) 
31.6 (3) 
0 (0) 
17.7 (1) 
0.0375±0.0052 
0.0171±0.0053 
0.0084±0.0041 
0.0030±0.0073 
0.0133±0.0037 
19 
40 
83 
230 
52 
 
Σ [1-227] 
216 
126 
15 
0 
1Zn 
2Zn 
1Cd 
2Cd 
(97) 
(75) 
(68) 
(83) 
(67) 
(74) 
(49) 
(47) 
(56) 
(57) 
(50) 
(90) 
(97) 
(78) 
(90) 
 
- 
 
- 
 
 
 
4.2.6 Effect of the inhibitor thiomandelate on HDX-MS for the different BcII 
protein species 
To determine the influence of (R,S)-thiomandelate on the flexibility of the different 
regions of the metal-substituted species namely Zn1, Zn2, Cd1 and Cd2-BcII species, 
the degree of H/D exchange of the inhibitor-free protein species were compared with 
their inhibited forms (see Table 4.3). The results show that only for the Cd2-BcII form 
of BcII, the H/D exchange decreases in presence of the inhibitor for the following 
regions: the H-X-H-X-D motif of P[82-110], the loop 56-60 of P[55-66] and the α-helix 
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V of P[220-227]. For all other metal-species, (R,S)-thiomandelate increases the H/D 
exchange of the different peptides.  
 
Table 4.3: Effects of binding of (R,S)-thiomandelic acid (TM) to Cd1-, Cd2-, Zn1-, and Zn2-
BcII. Comparison of un-inhibited and inhibited enzyme species (-). Percent deuteration is 
shown for a reaction time of 2000 s. 
 
 
To determine the binding mode of (R,S)-thiomandelate with the Cd1 and Zn1-BcII-
species, the theoretical H/D exchange (calculated from Equation 4.1) of the peptides 
of the inhibited species were compared with the experimental H/D exchange. In case 
of theoretical H/D exchange, positive cooperativity in metal binding was assumed. 
 
Equation 4.1: 
[ ] )(%)(%*5.0)(%*5.0% 12 BcIIMeDBcIIapoDTMBcIIMeDD −−−+−−=  
 
Figure 4.5 shows the difference of the percentage of deuteration for Zn1- (Figure 
4.5A) and for Cd1-BcII species (Figure 4.5B) with and without the presence of the 
 % Deuteration 
Residues Cd1-BcII Cd2-BcII Zn1-BcII Zn2-BcII 
 - TM - TM - TM  TM 
1-21 83,0 86,4 77,7 81,8 75,1 84,8 75,2 83,5 
22-31 29,2 42,4 24,6 26,4 30,4 44,6 23,9 29,5 
32-54 52,7 60,3 53,7 55,4 41,8 59,3 52,2 60,7 
55-66 57,5 58,9 45,9 30,5 44,9 53,9 30,9 35,7 
70-81 53,0 59,3 47,8 53,8 49,5 60,4 53,2 59,1 
82-110 73,2 75,0 59,4 53,0 61,5 71,1 49,4 59,4 
115-129 68,1 79,5 60,5 71,0 55,2 80,6 60,7 75,6 
130-138 77,3 82,8 74,1 78,9 61,1 81,0 70,6 89,6 
139-155 22,3 42,8 18,2 21,5 29,8 46,1 20,3 27,0 
156-164 21,4 30,5 22,3 27,3 18,1 29,5 22,3 28,7 
165-188 67,9 70,1 62,0 71,3 57,0 72,0 61,0 67,6 
189-205 34,9 50,3 32,9 38,0 45,1 49,4 35,2 40,4 
205-219 57,3 66,0 55,1 59,3 48,3 66,6 59,0 64,4 
220-227 13,1 44,6 35,1 22,7 34,5 50,4 19,4 23,2 
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inhibitor respectively. The values obtained for the inhibitor-bound form were 
subtracted from those of the ligand free form of the protein, thus positive values 
indicate an increased H/D-exchange for the (R,S)-thiomandelate containing species. 
The theoretical values of the H/D exchange are similar with to experimental ones for 
both metals, revealing that (R,S)-thiomandelate might induce positive cooperativity in 
metal binding for Cd(II) and Zn(II) ions in BcII. 
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Figure 4.5: Influence of (R,S)-thiomandelic acid binding on HDX of Me1-BcII. Experimental 
(black bars) and theoretical (grey bars) HDX data for Zn1BcII (A) and Cd1BcII (B) in presence 
of excess (R,S)-thiomandelic acid are compared. Changes of the percental deuterium 
incorporation after addition of the inhibitor to the Me1-species are shown for a reaction time of 
2000 s. Theoretical data were calculated assuming that all added metal ions were finally 
bound to inhibited Me2-enzyme (see equation 4.1). 
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4.3 DISCUSSION 
4.3.1 Metal-dependent protein structure and flexibility of BcII 
4.3.1.1 Comparison of the apo-BcII and Me2-enzyme 
Differences in secondary structures between the metal-free and the Me2-species of 
BcII were observed with CD spectroscopy and HDX-MS. For the CD spectra, the 
addition of two metal ions to the apoenzyme strongly increased the intensities of the 
negative band at 220 nm, indicating an increased content of secondary structure 
within the protein. One can conclude that parts of the secondary structure are not yet 
formed or sufficiently stabilized in metal-free BcII; potentially binding of the two 
metals either contributes to the stabilization of such structures or the binding of the 
metal ions induces conformational changes bringing residues in closer proximity thus 
finally enabling the formation of secondary structures. HDX-MS of pepsin-digested 
proteins permitted to localize the structural changes. The peptide P[82-110] 
containing the metal ion-binding HxHxD motif and its surrounding α-helix II showed 
very high solvent accessibility at early time HDX measurements for the metal-free 
enzyme. Together with CD spectra it can be concluded that the α-helical part must be 
partially unfolded in the apoprotein. This destabilization of secondary structure in this 
region would have a direct impact on the solvent accessibility of the neighbouring 
peptides. Indeed this was observed for the two peptides P[55-66] and P[115-129] 
containing the buried loop 56-60 and the loop connecting the N- and C-terminal 
domains, respectively. Both peptides showed high solvent accessibility in the metal 
free enzyme. In the crystal structure of Zn2-BcII (1BVT), P[115-129] is bound to P[82-
110] via 1 mc-mc and 3 mc-sc hydrogen bonds and P[55-66] forms 3 mc-mc and 3 
sc-sc hydrogen bonds including salt bridges of the guanidinium group of Arg91 to 
Asp 90 and Asp56. A strained conformation of the main chain at position 56 is 
induced which may be relevant for the structural organization of the metal binding 
site. This structural feature is strictly conserved among the MBLs (23). P[55-66] also 
contains Trp59 which was suggested to contribute to the binding of the phenyl group 
of penicillin via formation of a hydrophobic pocket with Phe34 . 
The absence of metal ions had also shown to influence regions far from the active 
site, as observed for the two peptides P[189-205] and P[220-227] which contain the 
α-helices IV and V, respectively, in the C-terminal tail of the protein. In the crystal 
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structure of the di-zinc form of BcII, a low B-factor was determined for the α-helix V, 
meaning that the position of its atoms have been determined with high precision. This 
can be due to the crystal packing of the BcII protein; two molecules are stacked 
against each other by their C-terminal α-helices (αV) (1BVT). However, in solution 
this region can be less stable especially in absence of metal ions. For all conditions 
tested HDX-MS analysis revealed a strong correlation between the flexibility of the 
fragments covering the α-helices IV and V and the peptide P[139-155] containing the 
metal ligand His149. 
Generally most regions of metal-free BcII showed faster HDX kinetics during 50 sec 
and 5900 sec than the metal-loaded states. This higher solvent accessibility of metal-
free BcII reflects a solution structure, which appears different from the known crystal 
structure of the Zn2-form. Previous NMR studies of backbones amide resonances by 
1H-15N-HSQC-experiments already resulted in significant differences between apo- 
and metal-loaded forms of BcII (11).  
Thus it can be assumed that metal ion binding strongly contributes to the stabilization 
of the protein fold observed in the crystal structure. The metal-free enzyme in solution 
might be partly unstructured at the interface site of N- and C-terminal domain and it 
might be concluded that the metal ion binding site is not pre-formed by the protein 
fold. By comparison of the crystal structure of the di-zinc and the metal-free form it 
was observed that the metal ions fulfill not only catalytic but also structural functions 
in the B. cereus metallo-ß-lactamase (141). The main differences in the Cα-positions 
were found close to the active site: in the absence of metal, the minor loop and the N-
terminus of the α-helix II (residues 87-93) showed larger distances between each 
other. Thus, in the metal-free form the connection between both regions, which is 
formed by the interaction between Asp183 and the side chain of the metal ligand 
His86 in case of the metal enzyme was disrupted. 
Thus binding of metal ions introduces additional bonds between N- and C-terminal 
domains which might be necessary to keep the domains connected. If the metal is 
absent, the N-and C terminal domains will be separated from each other, which can 
lead to an increased flexibility of the connecting loop, finally also influencing regions 
situated far from the active site. High flexibility of the apo-enzyme might also explain 
the ease of metal ion transfer from e.g. EDTA to the protein (4).  
 
  DISCUSSION: HDX-MS 
 
102
4.3.1.2 Comparing Cd2-and Zn2-BcII enzymes 
The analysis of the Me2-species using CD spectroscopy did not indicate significant 
differences between the secondary structure contents of the cadmium and the zinc 
enzymes. In contrast, the HDX-MS study revealed that the regions in the interface 
domain of the protein were more flexible for the Cd2-than for the Zn2-form of BcII. In 
fact, the two structurally coupled peptides namely P[55-66] and P[82-110] showed 
higher solvent accessibilities in case of the Cd2-form.  
The X-ray structure of B. fragilis zinc-ß-lactamase, another member of the subclass 
B1 enzymes, revealed a bridging solvent molecule between the two metals, which 
was assumed to exist as a hydroxide ion (27, 36). In the structure of the Zn2-BcII at 
pH 7.5, a similar bridging water molecule was found (33). This hydroxide ion may be 
involved in the nucleophile attack to the carbonyl carbon atom of the ß-lactam ring 
(21, 27, 30). Moreover, the distance of the shared solvent molecule to the cations 
was found to be higher in the Cd2 -form compared to the Zn2 -form of the B. fragilis 
enzyme (34). A higher distance between the two cadmium ions compared to the two 
zinc ions could have an influence on the stability of surrounding regions, as observed 
for the two peptides P[55-66] and P[82-110] in the BcII enzyme. 
 
4.3.1.3 Me1-BcII enzymes 
Metal jumping/flexibility of active site in the Cd1-BcII enzyme 
Previous NMR and PAC spectroscopic experiments demonstrated a fast exchange 
(jumping) of the single Cd2+ ion between the two metal binding sites in a time regime 
between 0.1 and 10 µs (11). De Seny et al., 2001 determined the dissociation rate koff 
for cadmium at 0.22 sec-1 for the BcII enzyme by combination of the association rates 
with the corresponding dissociation constants (39). The fast exchange of the Cd2+ ion 
between the two binding sites via a dissociation/association mechanism, where the 
metal ion is first transferred to the bulk water before binding again, however, would 
require a dissociation rate constant between 7x104 s-1 and 7x106 s-1. Consequently, 
the experimental koff is by 5-7 orders of magnitude too low for such a mechanism. 
Thus an alternative explanation for the rapid transfer between both binding sites can 
be given by the movement of the N- and C-terminal domain relative to each other. In 
fact, this movement enables a site-to-site metal ion transfer without the requirement 
to break all metal-protein bonds at the same time, thus indicating an intra-molecular 
  CHAPTER IV 
 
103
ligand exchange reaction. This would afford a rather flexible and highly dynamic 
protein structure, especially at the metal ion binding site. The observations of a less 
structured Cd1-enzyme in the CD spectra and highly labile protein regions at the 
domain interface with peptide (P[115-129]) and metal binding site (P[82-110] and 
P[55-66]) strongly support such a mechanism.  
 
Flexibility of BcII at [Zn2+]/[apoprotein] ratio of 1 
Based on the NMR/PAC results for the Cd1-BcII enzyme, a rapid exchange of the 
Zn2+ ion was also suggested in the zinc enzyme at [Zn2+]/[apoprotein] ratio of 1 using 
stopped-flow methods (39). In the past, the BcII enzyme was considered as a native 
monozinc enzyme, due to one high affinity (KD1) (nM) and one low affinity (KD2) (µM) 
dissociation constant for the binding of metal ions. In this case, only one metal-bound 
species, the mono-zinc form, can existent at a [Zn2+]/[apoprotein] ratio of 1. In the 
present study, competition titrations revealed that the KD2 value was revised by a 
factor of 2000 in BcII and the ESI-MS data detected the presence of three protein 
species, i.e. apo, Zn1- and Zn2 forms at low [Zn2+]/[apoprotein] ratios. Therefore the 
H/D kinetics obtained for each peptide at the investigated metal binding stoichiometry 
resulted from the superposition of the three coexisting species. In fact, the H/D 
exchange into the Zn1-form can not be followed separately from that of the other two 
protein species. Thus conclusions can not be drawn to explain a possible 
intramolecular exchange of the Zn2+ ion in the Zn1-enzyme. 
When one molar equivalent of zinc was added to the apoprotein the CD spectra 
indicated a modification of secondary structures compared to the situation found with 
two molar equivalents of zinc. Furthermore, it was found that certain regions revealed 
the best protection against H/D exchange, e.g. in the fragments P[156-164], P[205-
219] and P[32-54] at [Zn2+]/[apoprotein] ratio of 1. This was most pronounced for the 
peptide P[205-219] containing the metal ligand His210. These three fragments are 
spatial neighbouring regions in the crystal structure of the Zn2-BcII. Here, the 
formation of metal ion-bridged dimers of the protein at low [Zn2+]/[apoprotein] ratios 
might be responsible for the increase of protein stability, but has to be proved in 
further investigations.  
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4.3.2 The influence of the inhibitor thiomandelate on the protein flexibility of 
BcII 
4.3.2.1 Me2-species 
HDX-MS experiments presented in this work revealed that (R,S)-thiomandelate 
stabilized the Cd2-enzyme in the metal binding site, especially in the region of the H-
X-H-D motif and the coupled segment P[55-66]. Studying the Cd2-enzyme-inhibitor 
complex by NMR experiments revealed that the inhibitor binds to the two metals via 
its sulphur donating function (9). This has an impact on the stabilization of the two 
cadmium ions in the active site, which might explain a lower percentage of 
deuteration of P[55-66] in Cd2-BcII compared to the Zn2-BcII. The fragment P[55-66] 
contains also W59, whose side chain extends toward the ß3-ß4 loop. A shift of this 
residue was found in NMR experiments for the di-Zn2-BcII enzyme after the binding 
of the inhibitor (43). It was concluded that after binding of the inhibitor to the Zn2-
enzyme, the closing of the ß3-ß4 loop might cause the shift of the tryptophane 
residue. In the present study, an increased stability of the loop after inhibitor binding 
was not observed.  
In the Zn2-BcII enzyme the HDX-MS showed that no region of the protein was 
stabilized by (R,S)-thiomandelate. Indeed, in presence of the inhibitor all regions in 
the Zn2-BcII protein present similar or higher H/D exchanges compared to the 
inhibitor-free state. One possible explanation is that the high amount of inhibitor 
added to the Zn2-BcII enzyme might induce the formation of Zn1- or apo-enzyme. The 
inhibitor is known to have strong affinity for zinc ions in solution.  
 
4.3.2.2 Me1-species 
After binding of thiomandelate to the Me1-BcII species, the percentage of deuteration 
increased for all parts of the protein. It was concluded that the formation of 
apoenzyme, due to the positive cooperativity in metal binding of thiomandelate, was 
responsible for this high level of H/D exchange. Positive cooperativity in metal 
binding was also shown for the cadmium enzyme in NMR studies (9) as well as for 
the zinc enzyme in the presented competition titrations experiments. Thus, it was not 
possible to identify the regions in the Me2- species stabilized by the inhibitor, due to 
the high level of deuteration of the produced apoenzyme.  
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5 CONCLUSION AND OUTLOOK 
When combining miniaturization and automation in a nano-electrospray (nanoESI) 
device, such as the Nanomate® system, direct high-throughput screening can be 
easily reached for small-molecule protein interactions as it is the case in 
metalloenzyme-inhibitor complexes. The results obtained by ESI-MS for the binding 
of the inhibitors to the metallo-beta-lactamases via analysis of the relative abundance 
of the metalloprotein-inhibitor complexes were generally in good agreement with SAR 
data obtained in solution (43). In only one case, the order of binding strengths 
obtained in the gas phase was different from that obtained in solution. A different 
impact of non-covalent forces between inhibitors and proteins in the gas phase and 
in solution might explain the deviating results. In fact, electrostatic and hydrogen 
bonding interactions might be emphasized during ion transfer from solution into the 
gas phase, whereas the strength of hydrophobic interactions is reduced. Thus 
different equilibrium constants can be expected.  
The technique is also well suited for the rapid detection of metal:enzyme:inhibitor 
ratios, and in particular for the detection of the metal:protein stoichiometry. This 
information is often difficult to obtain by other methods, which are generally time-
consuming and demand high sample amounts. Besides that, the metal loading state 
of proteins is usually ignored in high-throughput studies on the inhibition of metallo-
enzymes. 
Competition titration experiments in combination with ESI-MS revealed that the 
inhibitor D-captopril preferentially binds to the dinuclear forms of zinc BcII and L1 
enzymes and the mononuclear form of the CphA enzyme. For (R,S)- thiomandelate 
two metal ions are required for efficient binding to BcII and L1 and unexpectedly to 
CphA, where formation of the dinuclear form was induced. In the CphA enzyme, the 
affinity for a second metal ion can only be increased by introducing a new metal 
ligand (i.e. the thiol group from (R,S)- thiomandelate. However, the increase of the 
affinity for a second metal ion might not be sufficient to inactivate the MBLs 
completely, due to the presence of catalytically active mononuclear species. One 
exception is BcII where positive cooperativity of zinc binding is induced by the 
presence of (R,S)- thiomandelate. To address the mononuclear forms of MBLs might 
be a major challenge in the design of new and clinically useful inhibitors. 
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HDX-MS was used to study the effect of metal ion binding on the flexibility of BcII, 
with special emphasis on the mononuclear forms. The data revealed a high flexibility 
at the active site and the interdomain region of the monocadmium enzyme, which 
might facilitate the known metal exchange between the two available ligand binding 
sites. This intramolecular exchange of the metal ion was also suggested for the 
mononuclear zinc enzymes. A highly flexible active site architecture of Zn1-MBLs 
might explain the difficulty to inhibit such enzymes.  
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APPENDIX 1: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 1: ESI mass spectra resulting from the incubation of apo-BcII (11.7) µM in 15 mM 
ammonium bicarbonate, pH 7) with different concentrations of Co(II) ions (2.5 to 30 µM). (*) 
represented the salt adducts. The ions carrying the charges + 9 and + 10 are representated 
in the mass spectra. Experiments were carried out at sample cone voltage 200 V, pressure 
at interface 6.7 mbar. 
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APPENDIX 2: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 2: Peptide mass fingerprint (PMF) of the apoenzyme BcII digested by pepsin in 
non deuterated buffer (A) and in deuterated buffer (B) analyzed in 5 mg/ml CCA 
(acetonitrile/ethanol/TFA 20/80/0.1) using MALDI-MS.  
 
 
 
 
 
 
 
 
 
 
 
 
 
1 0 0 0 1 2 0 0 1 4 0 0 1 6 0 0 1 8 0 0 2 0 0 0 2 2 0 0 2 4 0 0 2 6 0 0 2 8 0 0 3 0 0 0
m / z
 8 4 0 . 4 9
 9 5 3 . 6 1
1 0 2 6 . 6 4
1 1 5 9 . 7 9
1 2 4 1 . 7 3
1 2 9 2 . 8 5
1 3 8 0 . 9 0
1 5 1 1 . 9 4
1 6 1 1 . 0 1
1 7 2 3 . 9 3
1 7 8 0 . 0 6
1 8 3 7 . 0 5
1 9 3 6 . 1 3
1 9 9 7 . 2 4
2 0 6 9 . 2 9 2 2 0 9 . 4 2
2 3 1 3 . 5 5
2 3 8 6 . 5 8
2 5 0 3 . 4 8
2 6 7 8 . 6 3
2 7 9 0 . 6 9
1 0 0 0 1 2 0 0 1 4 0 0 1 6 0 0 1 8 0 0 2 0 0 0 2 2 0 0 2 4 0 0 2 6 0 0 2 8 0 0 3 0 0 0
m / z
 8 4 7 . 6 6
 9 6 4 . 6 2
1 0 1 6 . 8 5
1 1 5 8 . 8 4
1 2 4 0 . 7 6
1 2 9 0 . 9 0
1 3 7 8 . 9 3
1 4 4 8 . 9 2
1 5 0 9 . 9 5
1 5 6 2 . 0 0
1 7 2 2 . 9 5
1 8 6 5 . 1 7
1 9 3 6 . 1 5
1 9 9 5 . 2 6
2 0 6 6 . 2 9 2 2 0 6 . 3 8
2 3 0 7 . 5 0
2 3 8 3 . 5 8
2 5 0 1 . 5 2
2 5 7 2 . 5 2
2 6 7 0 . 5 6
2 7 8 3 . 6 6
2 8 3 5 . 8 2 2 9 4 9 . 7 4
Mass (m/z) 
A 
B 
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APPENDIX 3: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 3: Example of a MS/MS mass spectrum of a peptic peptide from the apoenzyme 
BcII digested with pepsin. The amino acid sequence of the peptide is NKNVWVHTEL with an 
experimental mass of m/z = 1239,650. The MS/MS fragmentation of the precursor peptide 
labeled with (*) leads mainly to the cleavage of the amide bonds, which produce b+-ions 
when the charge is retained by the amino-terminal fragment and y+-ions when it is retained 
by the carboxyl-terminal fragment. The b+-ions are consecutively labeled from the original 
amino terminus and the y+-ions from the original carboxyl terminus as represented in the inlet 
of the figure. 
 
 
 
 
  APPENDICES 
 
120
APPENDIX 4: 
 
Appendix 4: Determination of the percentage of deuterons back-exchanged (% BE) for each 
peptic peptide of the BcII enzyme during sample preparation for HDX experiments. In column 
1 and 2, the sequence of the analyzed peptides and the maximal number of observable 
deuterons (N) are given. In column 3 and 4, the experimental centroid mass of the 
undeuterated and nondeuterated peptides respectively are given. In column 5 and 6 the 
number of deuterons back exchanged and the percentage of deuterons back-exchanged is 
given respectively. % BE is calculated using the following equation:  
 
%100*1 


 −
−=
N
MMBE undeutdeut
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Sequence of 
identified peptides 
 
Maximal 
number 
of 
deuterons 
(N)  
Centroid 
Mass 
(Mundeut) 
Centroid 
Mass 
(Mdeut) 
Mdeut-
Mundeut 
BE (%) 
N-term. tail (β1, β2) 
 
    
1SQKVEKTVIK- 
NETGTISISQL21 20 2304.54 
 
2317.73 
 
 
13.19 
 
 
34.02 
 
β3, loop 32-39, β4, β5      
44LVLNTSKGLVL54 11 
 
1157.52 
 
 
1162.84 
 
 
5.32 
 
 
51.63 
 
22NKNVWVHTEL31 10 
 
1240.36 
 
 
1245.65 
 
 
5.29 
 
 
47.10 
 
32GSFNGEAVPS- 
NGLVLNTSKGLVL54 22 
 
2274.96 
 
 
2285.40 
 
 
10.44 
 
 
52.54 
 
Loop 55-66      
55VDSSWDDKLTKE66 12 
 
1423.49 
 
 
1430.72 
 
 
7.23 
 
 
39.75 
 
αI, β6      
71VEKKFQKRVTD81 11 
 
1378.71 
 
 
1384.08 
 
 
5.37 
 
 
51.18 
 
70MVEKKFQKRVTD81 12 
 
1509.84 
 
 
1515.79 
 
 
5.95 
 
 
50.37 
 
αII, β7      
82VIITHAHADR- 
IGGIKTLKER- 
GIKAHSTAL110 
29 
 
3108.37 
 
 
3122.88 
 
 
14.51 
 
 
49.95 
 
Connecting Loop, β8      
130VTNLKFGNM138 9 
 
1024.09 
 
 
1028.31 
 
 
4.22 
 
 
53.11 
 
115AKKNGYEEPL- 
GDLQT129 14 
 
1663.82 
 
 
1670.60 
 
 
6.78 
 
 
51.57 
 
114LAKKNGYEEPL- 
GDLQTVTNL133 19 
 
2204.45 
 
 
2214.68 
 
 
10.23 
 
 
46.16 
 
β9      
139KVETFYPGKG- 
HTEDN153 14 
 
1722.83 
 
 
1728.87 
 
 
6.04 
 
 
56.82 
 
139KVETFYPGKG- 
HTEDNIV155 16 
 
1935.08 
 
 
1942.85 
 
 
7.77 
 
 
51.44 
 
β10      
156VWLPQYNIL164 8  1146.54 
 
1152.75 
 
6.21 
 
22.37 
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156VWLPQYNIL164 8 
 
1146.54 
 
 
1152.75 
 
 
6.21 
 
 
22.37 
 
β11, Loop 174-185      
165VGGCLVKSTS- 
AKDLGNVADA- 
YVNE188 
24 2411.74 
 
2425.76 
 
14.02 
 
41.58 
 
αIV      
195NVLKRYRNIN204 10 
 
1290.49 
 
 
1295.36 
 
 
4.87 
 
 
51.30 
 
189WSTSIENVLK- 
RYRNIN204 16 
 
1994.21 
 
 
2003.63 
 
 
9.42 
 
 
41.09 
 
189WSTSIENVLK- 
RYRNINA205 17 
 
2065.53 
 
 
2075.22 
 
 
9.69 
 
 
43 
 
C-term. tail, β12, αV      
220LHTLDLLK227 8 
 
953.13 
 
 
956.70 
 
 
3.57 
 
 
55.39 
 
205AVVPGHGEVG- 
DKGLL219 14 
 
1448.67 
 
 
1455.00 
 
 
6.33 
 
 
54.78 
 
205AVVPGHGEVG- 
DKGLLL220 15 
 
1561.77 
 
 
1569.09 
 
 
7.32 
 
 
51.16 
 
205AVVPGHGEVG- 
DKGLLLHTLD- 
LLK227 
22 
 
2381.35 
 
 
2395.01 
 
 
13.65 
 
 
37.93 
 
 
 
